{"text": "In the usual care group , 22 patients had such a hospitalization , despite not undergoing a formal exercise program .Only 1 patient had an ICD discharge that caused at least 1 supervised exercise training session to fail to reach the target duration or intensity .", "label": "", "metadata": {}, "score": "42.162018"}
{"text": "In relatively stable outpatients with HF who were receiving contemporary medical treatment , symptoms of depression were associated with increased risk of death or cardiovascular hospitalization during a median 3-year follow - up .", "label": "", "metadata": {}, "score": "44.77592"}
{"text": "Of these 1186 patients , 472 suffered at least a second HF hospitalization and 218 experienced at least a third .Hospitalization for any cause occurred in 2587 patients after randomization , 1328 patients had at least two all - cause hospitalizations , and 718 patients had three or more .", "label": "", "metadata": {}, "score": "44.962856"}
{"text": "Of the estimated 1000 patients with HF seen at the program clinics during the study enrollment period , only patients meeting eligibility criteria were invited to participate in the study , and more than 80 % of these patients consented to participate .", "label": "", "metadata": {}, "score": "46.020737"}
{"text": "Finally , RCTs would only be included if they recruited more than 300 patients in total and planned follow - up of six months or greater .", "label": "", "metadata": {}, "score": "49.838303"}
{"text": "They were also more likely to have severe disease ( e.g. 62 - 66 % of hospitalized patients were in NYHA class III or IV vs. 49 % for patients with no HF hospitalization during the study ) .", "label": "", "metadata": {}, "score": "49.92679"}
{"text": "The absolute reduction in the primary event rate at 3 years was 4 % .At least 1 hospitalization was experienced in 729 patients ( 63 % ) in the exercise training group vs 760 ( 65 % ) in the usual care group .", "label": "", "metadata": {}, "score": "50.331284"}
{"text": "Mean 21 months .( nebivolol ) .37 lost .Table 2 .Patient characteristics of studies proposed for inclusion in meta - analysis .", "label": "", "metadata": {}, "score": "51.259583"}
{"text": "The ability to achieve a 13 % risk reduction for the end point of cardiovascular mortality or heart failure hospitalization is important , given the exceptional use of evidence - based therapies among the patients in this study at baseline and throughout the trial .", "label": "", "metadata": {}, "score": "51.34324"}
{"text": "2 - 4 Indeed , worsening HF is the most common cause of hospitalization in patients with HF and , when recurrent , presages death .", "label": "", "metadata": {}, "score": "51.49424"}
{"text": "The number of patients with a 1-mL /min / kg or greater improvement in peak oxygen consumption was 297 ( 33 % ) in the usual care group and 423 ( 44 % ) in the exercise training group .", "label": "", "metadata": {}, "score": "51.7274"}
{"text": "The 6-minute walk test also was performed at the 3-year and final visits .Patients made their final visit at the end of the study follow - up period or at 4 years .", "label": "", "metadata": {}, "score": "51.770638"}
{"text": "During each cycle of the model , patients could move between the four NYHA health states , experience sudden death , or have an unplanned hospitalization for a major cardiac event .", "label": "", "metadata": {}, "score": "51.859165"}
{"text": "Twenty - five patients withdrew their consent or were lost to follow - up prior to the end of the study or could not be included in the statistical analysis because of missing data even though they had completed the final visit .", "label": "", "metadata": {}, "score": "51.88846"}
{"text": "Our analysis has a number of strengths .The existing clinical trials provide considerable evidence for the long - term effectiveness of both CRT - P and CRT - ICD , but most patients were alive and many felt well at the end of the trials .", "label": "", "metadata": {}, "score": "52.262543"}
{"text": "Our observations also suggest that the presence of clinically significant depressive symptoms may have a notable effect on outcome , with approximately 56 % increased risk ( per unit of time ) for death or hospitalization .", "label": "", "metadata": {}, "score": "52.352264"}
{"text": "Table Graphic Jump Location Table 1 .The mean follow - up was 3 years ( range , 2 - 5 years ) ; no patients were lost to follow - up .", "label": "", "metadata": {}, "score": "52.44638"}
{"text": "Similarly , Vaccarino et al 6 reported that severity of depressive symptoms was related to death or functional decline at 6-month follow - up in 391 hospitalized patients with HF .", "label": "", "metadata": {}, "score": "52.453705"}
{"text": "This rate was higher than projected in the study design .After approximately 2000 patients were enrolled , unconditional power calculations based on the higher overall event rate revealed that the number of events required for 90 % statistical power could be achieved with 2300 patients rather than the original goal of 3000 .", "label": "", "metadata": {}, "score": "52.72902"}
{"text": "Since the introduction of those guidelines for both pharmacological and non - pharmacological treatment of HF patients , more patients have been treated with evidence based medication , [ 7 - 9 ] and clinical outcomes of fewer cardiovascular hospitalizations have been observed [ 10].", "label": "", "metadata": {}, "score": "52.753212"}
{"text": "Thus , additional hospitalizations , or supervening deaths , were recorded .All hospitalizations and deaths were adjudicated by an endpoint validation committee according to predefined criteria .", "label": "", "metadata": {}, "score": "53.104843"}
{"text": "In addition , all patients were asked to complete a physical activity questionnaire at the baseline , 6-month , 12-month , 24-month , 3-year , and final visits .", "label": "", "metadata": {}, "score": "53.164932"}
{"text": "Secondary end points included echocardiographic and functional classification assessments .Hospitalization or emergency department visit occurred in 30 pioglitazone and 15 glyburide participants , 19 and 12 of whom , respectively , continued treatment .", "label": "", "metadata": {}, "score": "53.186367"}
{"text": "Patients had a maximum of three implant attempts .Those patients who received a successful implant moved to the long - term model with an NYHA class according to the transition probabilities observed in the CARE - HF trial .", "label": "", "metadata": {}, "score": "53.199036"}
{"text": "6 - 8 Most of these previous studies showed positive effects of exercise training on exercise capacity , quality of life , and biomarkers and observed relatively few complications during training .", "label": "", "metadata": {}, "score": "54.142887"}
{"text": "The Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure ( OPTIMIZE - HF ) enrolled 5791 patients admitted with HF in a registry with prespecified 60- to 90-day follow - up at 91 academic and community hospitals throughout the United States .", "label": "", "metadata": {}, "score": "54.30502"}
{"text": "13 The incremental cost - effectiveness of CRT - P or CRT - ICD in different patient subgroups was also evaluated .Methods .Overview of CARE - HF .", "label": "", "metadata": {}, "score": "54.374393"}
{"text": "In the short - run , we assumed there was an immediate response to treatments at the end of the first month .Table 1 shows the estimated transition probabilities among NYHA classes based on available data derived from 388 ( 94.1 % ) and 380 ( 94.9 % ) patients in the CARE - HF CRT - P and MT groups , respectively .", "label": "", "metadata": {}, "score": "54.52778"}
{"text": "Based on the main analysis adjusted for heart failure etiology only , exercise training produced nonsignificant reductions in the primary end point ( all - cause mortality or all - cause hospitalization ) and in key secondary clinical end points .", "label": "", "metadata": {}, "score": "54.58232"}
{"text": "In fact , based on a survey of the patients after randomization , 55 % of patients in the usual care group were not satisfied with the study group to which they were randomly assigned , and many continued some level of physical activity .", "label": "", "metadata": {}, "score": "54.663445"}
{"text": "This is supported by the CARE - HF trial data . 7In the CARE - HF trial , outcomes including NYHA class have been measured at months 1 , 6 , 9 , and 12 , and every 6 months thereafter .", "label": "", "metadata": {}, "score": "54.87843"}
{"text": "Conclusion .In patients with heart failure and cardiac dyssynchrony , cardiac resynchronization reduced death and hospitalization for major cardiovascular events .Commentary .Pharmacologic therapy has tackled most of the pathophysiologic mechanisms of HF .", "label": "", "metadata": {}, "score": "54.89052"}
{"text": "6 , 13 We assumed no additional benefit apart from preventing sudden death attributable to ICD .The monthly probability of hospitalization has been reported to be similar for CRT - P and CRT - ICD in the COMPANION trial 12 ( 0.098 and 0.097 respectively ) , so no further penalty was applied to CRT - ICD patients for hospitalization rates due to the presence of the ICD component .", "label": "", "metadata": {}, "score": "55.519997"}
{"text": "The follow - up duration was also limited , and we could not , therefore , evaluate the long - term impact of adherence to care on outcome and particularly all - cause mortality or CHF mortality .", "label": "", "metadata": {}, "score": "56.128387"}
{"text": "Therefore , we also assessed whether antidepressant medication use at baseline was associated with death and hospitalization during 3 years of follow - up .This was a prospective observational follow - up study of nonhospitalized patients with HF recruited from outpatient HF clinics in central North Carolina .", "label": "", "metadata": {}, "score": "56.406326"}
{"text": "The within - trial analysis suggests that CRT - P might be cost - effective over a patients lifetime , but this has not been established with trial evidence .", "label": "", "metadata": {}, "score": "56.421486"}
{"text": "Patient deaths were verified through hospital and emergency medical services records .Cardiovascular hospitalizations included the following : occurrence of MI or stroke , treatment of worsening HF , and cardiac surgery including coronary artery bypass grafting , heart transplantation , and defibrillator or pacemaker implantation .", "label": "", "metadata": {}, "score": "56.472137"}
{"text": "21 - 25 Randomized cardiac resynchronization therapy trials have also consistently reported a reduction in admissions for worsening HF , including recurrent events .A reduction in HF hospitalizations has another important benefit that adheres not only to the individual patient , but also to society as a whole .", "label": "", "metadata": {}, "score": "56.567024"}
{"text": "Notably , limited postrandomization participation decreased power to detect a difference .The reduction in days hospitalized for trial participants overall underscores the benefit of CM for such HF patients .", "label": "", "metadata": {}, "score": "56.859257"}
{"text": "In our cohort of patients with HF , antidepressant medication use was associated with increased likelihood of death or cardiovascular hospitalization .Although patients taking antidepressants were more depressed despite their medication use , they had worse outcomes even after controlling for depression severity .", "label": "", "metadata": {}, "score": "56.965607"}
{"text": "This model - derived analysis extends our previously published within - trial analysis based upon 29.4 months of mean follow - up .9 It also further advances the work described in the COMPANION cost - effectiveness analysis which provided estimates of benefit at 7 years which are similar to those observed in our model at 6 years .", "label": "", "metadata": {}, "score": "57.01982"}
{"text": "The initial distribution of the NYHA classes , age , and gender , and subsequent transition probabilities and costs associated with treatment by MT or CRT - P + MT were based on the intention - to - treat analysis of the CARE - HF trial .", "label": "", "metadata": {}, "score": "57.141617"}
{"text": "The results of HF - ACTION should be interpreted in the context of the following potential limitations .The patients enrolled in this trial were relatively young compared with the general population with heart failure and did not have heart failure with preserved left ventricular function ( or diastolic heart failure ) .", "label": "", "metadata": {}, "score": "57.27069"}
{"text": "Early studies focused on improvement in functional capacity and surrogate physiologic markers .More recently , clinical trials have focused on \" harder \" outcomes , such as prevention of hospital admissions and progression of HF .", "label": "", "metadata": {}, "score": "57.36944"}
{"text": "2009;301(14):1451 - 1459 Link to Article .Whellan DJ , O'Connor CM , Lee KL , et al ; HF - ACTION Trial Investigators .Heart failure and a controlled trial investigating outcomes of exercise training ( HF - ACTION ) : design and rationale .", "label": "", "metadata": {}, "score": "57.47883"}
{"text": "2009;301(14):1451 - 1459 Link to Article .Whellan DJ , O'Connor CM , Lee KL , et al ; HF - ACTION Trial Investigators .Heart failure and a controlled trial investigating outcomes of exercise training ( HF - ACTION ) : design and rationale .", "label": "", "metadata": {}, "score": "57.47883"}
{"text": "All patients were to undergo baseline cardiopulmonary exercise testing .Test results were reviewed by investigators to ( 1 ) identify significant arrhythmias or ischemia that would prevent safe exercise training , ( 2 ) determine appropriate levels of exercise training , and ( 3 ) establish training heart rate ranges .", "label": "", "metadata": {}, "score": "57.535194"}
{"text": "For patients taking antidepressant drugs , NT - proBNP values were comparable to those in other patients ( 1479 \u00b1 1693 pg / mL vs 1476 \u00b1 1845 pg / mL ) .", "label": "", "metadata": {}, "score": "57.55861"}
{"text": "Details of the exercise training protocol have been reported .16 Patients were to begin home - based exercise after completing 18 supervised sessions and were to fully transition to home exercise after 36 supervised sessions .", "label": "", "metadata": {}, "score": "57.6561"}
{"text": "Patients were classified as \" better \" , \" unchanged \" or \" worse \" at the end of the study compared to baseline .Both a simple \" last visit carried forward \" ( LVCF ) analysis and \" worst rank carried forward \" ( WRCF ) analysis ( where patients who died were allocated NYHA class V ) were used .", "label": "", "metadata": {}, "score": "57.77713"}
{"text": "Mean 1.9 years . one lost .Age 18 to 75 ; NYHA III or IV .( bisoprolol ) .US - HF .Symptomatic HF .", "label": "", "metadata": {}, "score": "57.997894"}
{"text": "Similarly , 2 groups without HF were identified .Risks of all - cause death were obtained by the Kaplan - Meier method and Cox regression analyses .", "label": "", "metadata": {}, "score": "58.001915"}
{"text": "Patients randomized to the exercise training group first participated in a structured , group - based , supervised exercise program , with a goal of 3 sessions per week for a total of 36 sessions in 3 months .", "label": "", "metadata": {}, "score": "58.13886"}
{"text": "We conducted a randomized controlled clinical trial to explore the impact of supplementing nurse case management ( CM ) with the Intel Health Guide System ( HGS ) in an elderly population with HF and a high risk for rehospitalization .", "label": "", "metadata": {}, "score": "58.246128"}
{"text": "Methods : Medicare Advantage members with HF and recent hospitalization were randomized to THCM or CM .Consenting participants received THCM for 6 months or the health plan 's usual Medicare specialized CM as long as deemed necessary .", "label": "", "metadata": {}, "score": "58.249252"}
{"text": "Differences in health status between those who returned for the 12-month cardiopulmonary exercise test and those who did not also may have played a role .", "label": "", "metadata": {}, "score": "58.52926"}
{"text": "Most patients complained of breathlessness or fatigue , whereas , only less than half of them had symptoms of per- ipheral congestion .First - line assessment was made by ECG and X - ray in majority of patients .", "label": "", "metadata": {}, "score": "58.650517"}
{"text": "10 - 12 However , none has addressed the incremental cost - effectiveness of CRT - P vs. CRT - ICD , a more relevant and appropriate question , and none has been completed since the availability of the results from the CARE - HF trial .", "label": "", "metadata": {}, "score": "58.65975"}
{"text": "In 161 patients , 2D echocardiography was performed at baseline and after 6 months of CRT .Extent of LV dyssynchrony was calculated for each type of strain .", "label": "", "metadata": {}, "score": "58.672993"}
{"text": "In summary , we observed that increased symptoms of depression are associated with worsened prognosis and that HF disease severity does not account for the association of depression with adverse outcomes .", "label": "", "metadata": {}, "score": "58.989025"}
{"text": "Patients in the usual care group were not provided with a formal exercise prescription .All patients were asked to return for clinic visits every 3 months for the first 2 years of participation and yearly thereafter for up to 4 years .", "label": "", "metadata": {}, "score": "59.013348"}
{"text": "18 CRT - P + MT appeared cost - effective in all age groups .The cost - effectiveness of CRT - P + MT for patients in the ninth decade of life may seem surprising .", "label": "", "metadata": {}, "score": "59.283447"}
{"text": "13 Worsening HF is one of the most common causes of hospitalization in patients with HF and is often recurrent .Even though the rate of hospitalization for worsening HF has declined over several decades , it remains relatively high .", "label": "", "metadata": {}, "score": "59.297283"}
{"text": "Varying the period of follow - up in the model ( Table 9 ) indicates the sensitivity of the results for CRT - ICD + MT to the duration of follow - up being considered , effectively the duration of the patients ' exposure to the risk of sudden death .", "label": "", "metadata": {}, "score": "59.458893"}
{"text": "The cost - effectiveness of CRT - ICD + MT is substantially greater in younger subjects , due to the longer potential period when the subject is at risk of sudden death .", "label": "", "metadata": {}, "score": "59.711746"}
{"text": "5 - 7 We observed depression to be associated with adverse clinical events over and above the severity of HF .N -terminal pro - B - type natriuretic peptide , a valuable marker of HF severity , also was found to be highly related to risk of death or hospitalization in our study sample .", "label": "", "metadata": {}, "score": "59.732124"}
{"text": "The present database has enough subjects to examine the relationship between a GAI ( integrating several classes of medication ) and short - term outcomes .", "label": "", "metadata": {}, "score": "59.84417"}
{"text": "Multivariate analysis identified renal failure ( odds ratio , 15.2 ; 95 % confidence interval , 3.13 - 73.66 ) and insertion of the IABP after PCI ( odds ratio , 5.2 ; 95 % confidence interval , 1.09 - 24.76 ) as the only independent predictors of in - hospital mortality .", "label": "", "metadata": {}, "score": "59.865818"}
{"text": "At 12 months , the differences in cardiopulmonary exercise test results remained but there was no significant difference in distance in the 6-minute walk test .", "label": "", "metadata": {}, "score": "59.95745"}
{"text": "It is important to recognize that the main or primary analysis for the study that adjusted only for heart failure etiology did not result in a significant reduction in the primary end point or secondary end points .", "label": "", "metadata": {}, "score": "60.02153"}
{"text": "17 Event ( or censoring ) times for all patients were measured from the time of randomization ( time zero ) .All information available on the primary and secondary end points was collected until the time of final contact with the patient , including patients who withdrew consent or were lost to follow - up , at which point follow - up was censored .", "label": "", "metadata": {}, "score": "60.20349"}
{"text": "Participation began for both groups as telehealth systems were deployed between December 2008 and June 2009 .Case Management .All participants in both arms of the study received Aetna Medicare 's current standard CM services , which are designed to meet the frequently complex needs of older adults .", "label": "", "metadata": {}, "score": "60.272606"}
{"text": "Although the complication rate for all patients participating in cardiac rehabilitation has been reported to be extremely low , the complication rate for patients with heart failure in clinical trials of exercise training has been substantially higher .", "label": "", "metadata": {}, "score": "60.52641"}
{"text": "9 Thus , maximal benefit to society from HF therapy also requires the maintenance of benefits after initial hospitalization . 10However , most evaluations of HF therapy involve time - to - first event analyses and do not consider the impact of therapy after the initial event .", "label": "", "metadata": {}, "score": "60.592224"}
{"text": "13 When a participant was not specifically prescribed a \u03b2 - blocker or was not on the guideline - recommended target dose , the investigator was required to provide a specific reason in a dedicated case report form .", "label": "", "metadata": {}, "score": "60.610912"}
{"text": "Because depression in patients with HF is related to disease severity , however , there remains uncertainty about the extent to which depression , independent of HF severity , is related to adverse clinical outcomes . 8 In the last few years , B - type natriuretic peptide ( BNP ) and N -terminal proBNP ( NT - proBNP ) , which are released from the cardiac ventricles and have vasodilator and diuretic effects , have emerged as standard diagnostic and prognostic markers of HF . 9 , 10 In the present prospective study of 204 outpatients with HF , we used NT - proBNP to adjust for HF severity in evaluating whether symptoms of depression were related to death and hospitalizations during 3 years of follow - up .", "label": "", "metadata": {}, "score": "60.621887"}
{"text": "22 Our analysis indicates that CRT - ICD is cost - effective compared with CRT - P for patients with a reasonable life expectancy ( when treated ) .", "label": "", "metadata": {}, "score": "60.70622"}
{"text": "Introduction .Despite current intensive multidrug therapy , persons with heart failure ( HF ) are frequently admitted to hospital because of exacerbation of their symptoms and , once admitted , are often readmitted .", "label": "", "metadata": {}, "score": "60.736202"}
{"text": "Primary and secondary outcomes .The primary outcome for BB - HF will be all - cause mortality , including deaths recorded after publication of the trial , where these data are available .", "label": "", "metadata": {}, "score": "60.764084"}
{"text": "The baseline survival function for time to cardiovascular unplanned hospitalization was derived from the time to first unplanned hospitalization using a Weibull survival function .Table 3 shows the estimated hazards ratios by different NYHA class with NYHA class I as reference case .", "label": "", "metadata": {}, "score": "60.772293"}
{"text": "Patient follow - ups were censored at the time of death or at the end of the study .Both approaches were adjusted for prognostic factors .", "label": "", "metadata": {}, "score": "60.84925"}
{"text": "Patients also were contacted annually by mail and asked to indicate whether they had been hospitalized during the past year and to provide consent for retrieval of their medical records for each hospitalization .", "label": "", "metadata": {}, "score": "60.909775"}
{"text": "Our primary hypothesis was that in patients with stable heart failure , regular structured exercise training , when added to usual , evidence - based care in accordance with published guidelines , would significantly reduce the incidence of a combined end point of all - cause mortality or all - cause hospitalization .", "label": "", "metadata": {}, "score": "61.021458"}
{"text": "Perhaps the most important patient factor that affects prescription of evidence - based therapy is age .In most population - based studies the incidence and prevalence of HF increases with age and the average age of prevalent HF is about 75 years .", "label": "", "metadata": {}, "score": "61.059883"}
{"text": "For the eight 3-month windows in the first 2 years , 22 % to 28 % of patients , depending on time point , stated during every telephone call in the 3-month window that they were exercising .", "label": "", "metadata": {}, "score": "61.06491"}
{"text": "GAI3 and GAI5 were continuous vari- ables.14It was anticipated that higher GAI values would be associ- ated with longer times to re - hospitalization .A Cochrane - Armitage test was performed in order to evaluate whether the rate of CV hos- pitalization was different among three adherence groups .", "label": "", "metadata": {}, "score": "61.267715"}
{"text": "Patient age .While the base case assumed a starting age of 65 , this was varied in sensitivity analyses to examine the extent to which patient starting age ( and thus life expectancy ) affected the results of the model .", "label": "", "metadata": {}, "score": "61.326225"}
{"text": "Discussion .For the base case , CRT - P appears a highly cost - effective addition to MT among eligible patients .CRT - ICD + MT also appears cost - effective compared with MT , although this may not be considered an appropriate comparison as the treatment with high cost relative to benefits may appear cost - effective when combined with a highly cost - effective regimen .", "label": "", "metadata": {}, "score": "61.37912"}
{"text": "To provide comparable levels of attention from study personnel in the 2 study groups , all patients were to be called every 2 weeks for the first 9 months , monthly until 24 months of follow - up , and quarterly thereafter .", "label": "", "metadata": {}, "score": "61.386566"}
{"text": "Although a number of sub - group and meta - analyses based on published data have been conducted [ 8 , 9 ] , these can only address reported outcomes and are limited statistically .", "label": "", "metadata": {}, "score": "61.456604"}
{"text": "Source Citation .Abstract .Question .In patients receiving standard medical therapy for moderate or severe heart failure ( HF ) with cardiac dyssynchrony , does cardiac resynchronization ( CR ) decrease the risk for complications and death ?", "label": "", "metadata": {}, "score": "61.57329"}
{"text": "Patients with additional HF hospitalizations had more severe disease than those without .Similar observations were made for all - cause and cardiovascular hospitalizations .Conclusion Treatment with ivabradine , on a background of guidelines - based HF therapy , is associated with a substantial reduction in the likelihood of recurrent hospitalizations for worsening HF .", "label": "", "metadata": {}, "score": "61.619537"}
{"text": "Heart failure etiology was ischemic in 51 % , and median left ventricular ejection fraction was 25 % .Exercise adherence decreased from a median of 95 minutes per week during months 4 through 6 of follow - up to 74 minutes per week during months 10 through 12 .", "label": "", "metadata": {}, "score": "61.754936"}
{"text": "Measures included total hospital inpatient days , ED visits , primary care visits , specialist visits , prescriptions filled for selected types of cardiac medication , and the subset of hospital admission and ED visits for cardiovascular cause .", "label": "", "metadata": {}, "score": "61.968784"}
{"text": "The CRT - P and CRT - ICD groups received treatment with their assigned therapy in accordance with the successful device implantation rates observed in the CARE - HF trial . 7", "label": "", "metadata": {}, "score": "62.009148"}
{"text": "Kaplan - Meier estimates for the time to CV hospitalization on the basis of adherence measures were obtained and a log - rank test was used to test differences between the three adherence groups .", "label": "", "metadata": {}, "score": "62.0762"}
{"text": "Sixty - five percent did not want to be dependent on a CDSS .Nevertheless thirty - six percent of HF nurses and 50 % of cardiologists stated that a CDSS can optimize HF medication .", "label": "", "metadata": {}, "score": "62.164215"}
{"text": "Participants in THCM transmitted their weight and blood pressure as often as every weekday .Periodically , they were asked to input responses about medication adherence , exercise , and any recent ED visits or hospital stays .", "label": "", "metadata": {}, "score": "62.171303"}
{"text": "Overall , telemonitoring increased the case manager activity required per participant , and participant satisfaction and adherence were high .A 42 % reduction in inpatient days during the intervention period compared with the previous year suggested positive overall impact of case management .", "label": "", "metadata": {}, "score": "62.173946"}
{"text": "To our knowledge , this is the first report of the direct impact of a global prescribing score on the outcome in an outpatient heart failure population in actual practice .", "label": "", "metadata": {}, "score": "62.21831"}
{"text": "Educational content was also available to participants on demand through the HGS .Case managers were instructed to check the Web - based clinical user interface for alerts on each member 's condition and to respond with care coordination assistance as needed .", "label": "", "metadata": {}, "score": "62.304115"}
{"text": "Mortality was sub - classified by cause including : death due to worsening heart failure ; sudden death ; death due to all other causes .", "label": "", "metadata": {}, "score": "62.3572"}
{"text": "A gap - time approach was used for patients with at least one hospitalization during the study .This approach considers the time from the onset of the first post - randomization hospitalization until the onset of the second using a Cox proportional hazards model and enables a non - randomized comparison of the time to the second event between the treatment groups .", "label": "", "metadata": {}, "score": "62.37732"}
{"text": "Secondary endpoints included the individual components of the primary endpoint , HF deaths , all - cause hospitalizations , and combinations of these with and without hospitalization for non - fatal myocardial infarction .", "label": "", "metadata": {}, "score": "62.386734"}
{"text": "23 , 24 In the CHARM trial and the Valsartan Heart Failure Trial , only 55 % and 35 % of patients , respectively , received \u03b2 - blocker therapy , and an ICD was reported in only 2.4 % to 2.6 % of patients enrolled in CHARM .", "label": "", "metadata": {}, "score": "62.403385"}
{"text": "We assessed the cost - effectiveness of CRT - P compared with medical therapy ( MT ) alone , and the cost - effectiveness of CRT - ICD + MT compared with CRT - P + MT , on incremental cost per quality adjusted life year ( QALY ) and life year using data from two landmark clinical trials .", "label": "", "metadata": {}, "score": "62.415947"}
{"text": "CR therapy is here to stay in selected patients with HF .The question of whether implantable - cardioverter therapy alone or combined with CR will further reduce mortality is currently being addressed by the Resynchronzation / Defibrillation for Advanced Heart Failure ( RAFT ) and Multicenter Automatic Defibrillator Implantation Trial - Cardiac Resynchronization Therapy ( MADIT - CRT ) trials .", "label": "", "metadata": {}, "score": "62.519573"}
{"text": "Havraneck EP , Abrams F , Stevens E et al .Determinants of mortality in elderly patients with heart failure .Arch Intern Med 1998;158 : 2024 - 2028 .", "label": "", "metadata": {}, "score": "62.776024"}
{"text": "Reference .Bradley DJ , Bradley EA , Baughman KL , et al .Cardiac resynchronization and death from progressive heart failure : a meta - analysis of randomized controlled trials .", "label": "", "metadata": {}, "score": "62.7777"}
{"text": "Telehealth alerts prompted frequent telephonic contact , increasing THCM case managers ' workload .The participant population overall had 42 % fewer inpatient days during the intervention period compared with the previous year .", "label": "", "metadata": {}, "score": "62.85742"}
{"text": "Morbidity and mortality rates in patients with HF - PSF are high but not quite as high as in patients with reduced systolic function .Though much has recently been learned about the syndrome of HF - PSF , many questions remain to be answered , not least how it should be treated .", "label": "", "metadata": {}, "score": "62.88836"}
{"text": "We know that women with HF have different prognostic indicators than men , such as older age , more hypertension and higher ejection fraction , are less likely to receive guideline therapies , and have longer hospital stays [ 28 , 30 , 31 ] .", "label": "", "metadata": {}, "score": "62.99762"}
{"text": "The multivariate regression analyses also included numerous covariates to control for any differences between the groups , including age , state of residence , presence of various comorbid conditions , and prior cardiac events including coronary artery bypass surgery .", "label": "", "metadata": {}, "score": "63.003567"}
{"text": "3 , 15 Moreover , a BDI score of 10 or higher has been associated with poorer prognosis in a variety of populations with cardiac disease .", "label": "", "metadata": {}, "score": "63.034317"}
{"text": "Most patients were taking a \u03b2 - blocker ( 88.7 % ) or an angiotensin - converting enzyme inhibitor ( 87.2 % ) .The BDI score at baseline ranged from 0 to 37 ( mean score , 10.3 ) .", "label": "", "metadata": {}, "score": "63.06391"}
{"text": "Eighty - three patients ( 4 % ) withdrew consent at a median time of 6.8 months following randomization .A total of 736 patients completed 36 supervised training sessions with the median time to completion ( for 36 sessions ) of 3.9 months ( interquartile range , 3.4 - 4.8 months ) .", "label": "", "metadata": {}, "score": "63.145752"}
{"text": "Page 5 .Treatment profile , adherence to treatment guidelines , and impact on outcome We found that the overall physician adherence to ESC treat- ment guidelines was 63 % .", "label": "", "metadata": {}, "score": "63.167137"}
{"text": "18 Depression has been related to reduced heart rate variability , 19 blunted baroreflex sensitivity , 20 heightened sympathetic nervous system activity , 21 blood hypercoagulability , 22 increased inflammation , 23 and endothelial dysfunction .", "label": "", "metadata": {}, "score": "63.192215"}
{"text": "SOLVD Investigators .Circulation 1992;86:431 - 438 .Flather M , Yusuf S , Kober L et al .Long term ACE - inhibitor therapy in patients with heart failure of left ventricular dysfunction : a systematic overview of data from individual patients .", "label": "", "metadata": {}, "score": "63.207993"}
{"text": "Further , the balance of efficacy and safety remains uncertain for common groups including older persons , women , those with impaired renal function and diabetes .", "label": "", "metadata": {}, "score": "63.265488"}
{"text": "Other important controversies that can be addressed by this IPD analysis include the effects of beta - blockers in patients with HF and atrial fibrillation [ 34 - 36 ] , and the interaction of benefit with heart rate , blood pressure changes and achieved dose [ 37 , 38 ] .", "label": "", "metadata": {}, "score": "63.27224"}
{"text": "For CM , case closure occurred when member goals were deemed met .For THCM , CM continued throughout the monitoring period .Thus , in some cases THCM members received CM longer than members in CM alone .", "label": "", "metadata": {}, "score": "63.31313"}
{"text": "We , therefore , retrospectively studied 48 patients who had undergone primary PCI with IABP because of cardiogenic shock complicating acute myocardial infarction ( 26 patients received the IABP before and 22 patients after primary PCI ) .", "label": "", "metadata": {}, "score": "63.333782"}
{"text": "a Indicates the rate of implant success based on data from the CARE - HF trial .b The probability that NYHA class III / IV patients will transition to NYHA class I - IV in the month following CRT ( \u00b1 ICD ) implantation is shown .", "label": "", "metadata": {}, "score": "63.43554"}
{"text": "The risk for suffering a third hospitalization for worsening HF was also significantly reduced by ivabradine ( Figure 2 ) .Estimate of treatment effect on recurrence of hospitalizations for worsening heart failure ( total - time approach ) .", "label": "", "metadata": {}, "score": "63.753803"}
{"text": "Physicians reported the primary cause of hospitalizations and these were classified as CHF , other CV hospitalizations , or non - CV hospitalizations on the basis of their diagnoses .", "label": "", "metadata": {}, "score": "63.87838"}
{"text": "In clinical practice , dose titration of these drugs is usually driven by assessment of patients ' clinical and volume status .However , up - titration of medications in chronic HF remains suboptimal in clinical practice , with administered doses often lower than those utilized in clinical trials , preventing achievement of the full benefit of evidence - based therapies [ 5 ] , [ 6].", "label": "", "metadata": {}, "score": "63.905487"}
{"text": "Demographic and clinical characteristics of the study sample are given in Table 1 .Patient mean age at baseline was 56.8 years ( age range , 27 - 88 years ) .", "label": "", "metadata": {}, "score": "64.04853"}
{"text": "Unplanned hospitalizations were categorized by type : procedure - related ; non - procedure - related ; and those leading to death due to worsening heart failure .", "label": "", "metadata": {}, "score": "64.052315"}
{"text": "The follow - up period ended March 15 , 2008 .The median duration of follow - up for the primary end point was 30.1 months ( goal of a minimum of 1 year and a maximum of 4 years ) .", "label": "", "metadata": {}, "score": "64.09873"}
{"text": "Outcome Measures and Statistical Analyses .The primary outcome measure was admission to an acute care hospital , an ED visit , or death during the measurement period , as determined through claims and Medicare eligibility data .", "label": "", "metadata": {}, "score": "64.19683"}
{"text": "16In addition , we explored the effect of ivabradine on the total number of repeated all - cause and cardiovascular hospitalizations , including hospitalization for causes other than worsening HF .", "label": "", "metadata": {}, "score": "64.25635"}
{"text": "A total - time approach was used for all randomized patients , considering times from randomization to the onset of first , second , third , and each subsequent hospitalization using a Wei , Lin , and Weissfeld model , employing robust sandwich estimators for standard errors .", "label": "", "metadata": {}, "score": "64.27871"}
{"text": "All patients hospitalized with first - time AMI ( 2000 through 2005 ) and not undergoing PCI within 30 days from discharge were identified in national registers .", "label": "", "metadata": {}, "score": "64.33392"}
{"text": "Conclusions .Long - term treatment with CRT - P + MT appears cost - effective compared with MT alone .Acknowledgements .This study was funded by an unrestricted research grant from Medtronic Inc.", "label": "", "metadata": {}, "score": "64.44155"}
{"text": "g ) .Develop a risk model for patients with HF using key baseline characteristics to allow clinicians to accurately assess prognosis in individual patients .", "label": "", "metadata": {}, "score": "64.45049"}
{"text": "Values for age , HF etiology , and LVEF are given in Table 2 .No additional variables were added to the model through stepwise selection .", "label": "", "metadata": {}, "score": "64.48919"}
{"text": "Three visits were performed at baseline 3 and 6 months .At base- line , social and demographic data were recorded together with life- style , risk factors , cardiovascular ( CV ) history , clinical profile , diagnostic procedures , and medical treatment .", "label": "", "metadata": {}, "score": "64.52884"}
{"text": "20 The overall interpretation of the results , then , is that this structured exercise training intervention had at best a modest effect on clinical end points in a large cohort of patients .", "label": "", "metadata": {}, "score": "64.53014"}
{"text": "The recruitment goal was con- sidered sufficient to detect a 40 % difference in hospitalization rates between NYHA Class II and III patients with 80 % power .", "label": "", "metadata": {}, "score": "64.56974"}
{"text": "Changes from baseline in NYHA class were compared between treatment groups using ordinal logistic regression .An independent data and safety monitoring board was appointed by the National Heart , Lung , and Blood Institute to review the interim results of the study and evaluate patient safety and trial feasibility on a semiannual basis .", "label": "", "metadata": {}, "score": "64.57198"}
{"text": "Accordingly , non - adherence could be either a cause or a marker of poor outcome .As many ambulatory CHF patients can be controlled without long - term use of diuretic agents , this may have impacted on the ' non - adherence ' score of GAI5 despite appropriate therapy .", "label": "", "metadata": {}, "score": "64.66147"}
{"text": "Discussion Population profile and adherence to diagnosis guidelines We enrolled a large European population with mild - to - mod- erate heart failure .Unlike previous surveys , we carefully selected investigators by randomization and not on a volun- tary basis in the six countries involved in the study in order to avoid both patients and physicians profile bias .", "label": "", "metadata": {}, "score": "64.737076"}
{"text": "In taking a life - time approach , we have been able to consider important issues such as device replacement , which none of the existing trials has had long enough follow - up to address .", "label": "", "metadata": {}, "score": "64.76739"}
{"text": "Heart failure ( HF ) is characterized by markedly compromised cardiac function , high rate of complications , and decreased life expectancy .1 Impaired cardiac function and neurohumoral activation are the defining characteristics of HF that contribute to clinical deterioration , and the focus of interventions has generally been on improving circulatory function and on blocking the renin - angiotensin and sympathetic nervous systems .", "label": "", "metadata": {}, "score": "64.836044"}
{"text": "At 12 months , the median time spent walking was 75 minutes per week in the usual care group vs 140 minutes per week in the exercise training group .", "label": "", "metadata": {}, "score": "64.84331"}
{"text": "For example , diabetes is present in about 25 % of patients enrolled in the larger trials of beta - blockers in HF .The risk of mortality and other complications is higher in diabetics but meta - analysis of published tabular data has suggested that the absolute mortality reduction using beta - blockers may be less in patients with diabetes [ 25 ] .", "label": "", "metadata": {}, "score": "64.843956"}
{"text": "To avoid introducing bias , the variables selected were required to have little or no missing data .Heart failure etiology ( ischemic vs nonischemic ) , which was a stratification factor in the randomization , was included as a covariate in all time - to - event analyses .", "label": "", "metadata": {}, "score": "64.93859"}
{"text": "2011;17(3):e71-e79 ) .Medicare Advantage members with heart failure and recent hospitalization were randomized to home telemonitoring with case management or case management alone .", "label": "", "metadata": {}, "score": "64.94805"}
{"text": "The aims and objectives of the BB - HF individual patient data meta - analysis include : . a ) .Provide a definitive estimate of the overall treatment effect of beta - blockers in HF on key outcomes including all - cause mortality and hospitalization .", "label": "", "metadata": {}, "score": "65.06972"}
{"text": "Mean 2 years .( bucindolol ) .NYHA III or IV ; . eight lost .Digoxin in all patients pre-1997 .CHRISTMAS .Stable HF due to CAD . one lost .", "label": "", "metadata": {}, "score": "65.11496"}
{"text": "17 Each set of random input values was drawn on the bass of their specific distributions for every 10 000 patients and the results were iterated 1000 times .", "label": "", "metadata": {}, "score": "65.19489"}
{"text": "We based the study design on the traditional 36-session cardiac rehabilitation model , followed by regular home exercise .Unlike the study by Belardinelli et al , 6 evaluating a strategy of only supervised training was not feasible , and it is unlikely that such a strategy would be adopted in practice .", "label": "", "metadata": {}, "score": "65.33905"}
{"text": "Importantly , we propose a statistically - robust sub - group assessment according to age , gender , diabetes and other key factors ; analyses which are only achievable using an individual patient data meta - analysis .", "label": "", "metadata": {}, "score": "65.36181"}
{"text": "6 Two meta - analyses suggested improved survival and decreased hospitalizations for patients with heart failure undergoing exercise training compared with a non - exercising control group .", "label": "", "metadata": {}, "score": "65.39914"}
{"text": "The exercise training goal during this time was 90 minutes per week .In the third year of follow - up , patients in the exercise training group were exercising a median of 50 minutes per week ( interquartile range , 0 - 140 minutes per week ) .", "label": "", "metadata": {}, "score": "65.51257"}
{"text": "Our observations associating antidepressant medication use with poorer prognosis in patients with HF were unexpected and should be interpreted cautiously because of their novelty and the absence of an established explanatory mechanism .", "label": "", "metadata": {}, "score": "65.57509"}
{"text": "In total , 6505 patients in 37 countries ( 677 medical centres ) were randomly allocated to either placebo or ivabradine ( beginning with 5 mg b.i.d . , which could be titrated to 7.5 or 2.5 mg b.i.d . , or stopped , depending on heart rate and tolerability ) .", "label": "", "metadata": {}, "score": "65.84218"}
{"text": "The outcome variable was time to any CV hospitalization ( including both CHF and other CV causes ) .All factors which were significant at the 5 % alpha level in univariate analysis were used in a multi - variate model .", "label": "", "metadata": {}, "score": "65.84862"}
{"text": "Whellan DJ , Gaulden L , Gattis WA et al .The benefit of implementing a heart failure disease management program .Arch Intern Med 2001;161 : 2223 - 2228 .", "label": "", "metadata": {}, "score": "65.90852"}
{"text": "( bisoprolol ) .NYHA III or IV . six lost .MERIT - HF .Symptomatic HF .All - cause mortality ; All - cause mortality plus all - cause hospitalization .", "label": "", "metadata": {}, "score": "65.98541"}
{"text": "Hambrecht R , Niebauer J , Fiehn E , et al .Physical training in patients with stable chronic heart failure : effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles .", "label": "", "metadata": {}, "score": "66.10094"}
{"text": "Hambrecht R , Niebauer J , Fiehn E , et al .Physical training in patients with stable chronic heart failure : effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles .", "label": "", "metadata": {}, "score": "66.10094"}
{"text": "In the mid-1990s , the astute identification of a prolonged QRS complex duration as a marker of mortality in patients with HF determined the rapid development of CR and paved the way to finally completing the foundations for HF therapy .", "label": "", "metadata": {}, "score": "66.150375"}
{"text": "NYHA class distribution and transitions , associated health utilities , rates and cause of hospitalization and death were estimated from individual patient data from the CArdiac REsychronization in Heart Failure ( CARE - HF trial ) .", "label": "", "metadata": {}, "score": "66.38946"}
{"text": "HF : .Heart failure .IPD : .Individual Patient Data .LV : .Left Ventricular .MDC : .Metoprolol in Idiopathic Dilated Cardiomyopathy Study .", "label": "", "metadata": {}, "score": "66.41141"}
{"text": "M.J.C. has received salary support from grants funded by Medtronic Inc. .Conflict of interest : Medtronic Inc. , who funded this study , had the option to comment upon the final draft of the manuscript .", "label": "", "metadata": {}, "score": "66.4308"}
{"text": "For THCM , a member experience and satisfaction survey ( 5-point Likert scale with responses ranging from strongly disagree to strongly agree ) was administered directly via HGS at the end of the study .", "label": "", "metadata": {}, "score": "66.45692"}
{"text": "This paper evaluating the effect of continued treatment with ivabradine on recurrent hospitalizations for worsening HF is based on post hoc analysis .The statistical models used have limitations .", "label": "", "metadata": {}, "score": "66.45838"}
{"text": "Cohort studies of hospitalized patients show a smaller proportion of HF - PSF .Compared to those with reduced systolic function , patients with HF - PSF are more often female , older , less likely to have coronary artery disease , and more likely to have hypertension .", "label": "", "metadata": {}, "score": "66.4989"}
{"text": "In comparison , IPD allows a full time - to - event analysis addressing each event from the time of randomization .The hazard ratio obtained provides a more appropriate view of survival and accounts for censored patients .", "label": "", "metadata": {}, "score": "66.502106"}
{"text": "Design : Randomized controlled trial ( Cardiac Resynchronization - Heart Failure [ CARE - HF ] ) .Exclusion criteria were a major cardiovascular event in the previous 6 weeks , conventional indications for pacemaker or implantable defibrillator , HF requiring continuous intravenous therapy , or atrial arrhythmia .", "label": "", "metadata": {}, "score": "66.52688"}
{"text": "Search strategy and eligible studies .A number of large trials were discussed in detail but were not included .Further , the beta - blocker phase of the trial involved a follow - up period of only 24 weeks .", "label": "", "metadata": {}, "score": "66.58713"}
{"text": "Bensimhon DR , Leifer ES , Ellis SJ , et al ; HF - ACTION Trial Investigators .Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure ( from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing ) .", "label": "", "metadata": {}, "score": "66.58908"}
{"text": "Bensimhon DR , Leifer ES , Ellis SJ , et al ; HF - ACTION Trial Investigators .Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure ( from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing ) .", "label": "", "metadata": {}, "score": "66.58908"}
{"text": "11 Our supplementary post hoc analysis is consistent with the conclusion that the benefit of ivabradine on HF hospitalization is maintained over several years of therapy and , specifically , mitigates the likelihood of recurrent events .", "label": "", "metadata": {}, "score": "66.61005"}
{"text": "Renal impairment is a common co - morbidity in HF that limits therapy .However , existing ( under - powered ) data suggest that beta - blockers are effective regardless of baseline renal function [ 32 , 33 ] .", "label": "", "metadata": {}, "score": "66.75139"}
{"text": "THEN guidelines apply .IF Guidelines applies AND patient is on glycosides at baseline THEN guidelines are met .Page 4 .Table 4 gives the statistically significant factors predicting time to CV hospitalizations that were included in the multi- variate model .", "label": "", "metadata": {}, "score": "66.76338"}
{"text": "PubMed View Article .van Veldhuisen DJ , Aass H , El Allaf D , Dunselman PH , Gullestad L , Halinen M , Kjekshus J , Ohlsson L , Wedel H , Wikstrand J , MERIT - HF Study Group : Presence and development of atrial fibrillation in chronic heart failure .", "label": "", "metadata": {}, "score": "66.773926"}
{"text": "5 - 7 Thus , a reduction in HF admissions contributes to a reduction in the overall burden of HF on patients and to a reduction in the risk of subsequent hospitalizations and death .", "label": "", "metadata": {}, "score": "66.89236"}
{"text": "Primary End Point and Its Components .Kaplan - Meier curves depicting the primary end point of death or hospitalization from any cause for each randomized group are shown in Figure 2 .", "label": "", "metadata": {}, "score": "66.951996"}
{"text": "The target training regimen for home exercise was 5 times per week for 40 minutes at a heart rate of 60 % to 70 % of heart rate reserve .", "label": "", "metadata": {}, "score": "66.97627"}
{"text": "These limitations include a small sample size and the absence of propensity matching , which may preclude optimal control for potentially confounding variables .We did not have information about duration of antidepressant use , and we did not know whether depressive symptoms were stable , remitting , or worsening .", "label": "", "metadata": {}, "score": "66.97847"}
{"text": "Curtis LH , Whellan DJ , Hammill BG , et al .Incidence and prevalence of heart failure in elderly persons , 1994 - 2003 .", "label": "", "metadata": {}, "score": "67.052475"}
{"text": "Curtis LH , Whellan DJ , Hammill BG , et al .Incidence and prevalence of heart failure in elderly persons , 1994 - 2003 .", "label": "", "metadata": {}, "score": "67.052475"}
{"text": "These as - treated analyses compared outcomes for THCM members who consented and had HGS installed with those of members who began the CM intervention during the same time period .", "label": "", "metadata": {}, "score": "67.05586"}
{"text": "The CARE - HF trial puts the final nail in the coffin of the question of whether CR reduces mortality in patients with moderate - to - severe medically refractory HF , regardless of the cause .", "label": "", "metadata": {}, "score": "67.07347"}
{"text": "Discussion .This benefit is reflected by a reduction in total hospitalizations for worsening HF , in the incidence of recurrent HF hospitalizations , and in an increase in time to first and subsequent hospitalizations .", "label": "", "metadata": {}, "score": "67.0753"}
{"text": "The changes from baseline in peak oxygen consumption and distance in the 6-minute walk test at 3 months and 1 year are presented in Table 4 .", "label": "", "metadata": {}, "score": "67.117676"}
{"text": "Results .Conclusions .The continuation of \u03b2 - blocker therapy in patients hospitalized with decompensated HF is associated with lower postdischarge mortality risk and improved treatment rates .", "label": "", "metadata": {}, "score": "67.191376"}
{"text": "The Collaborative Group decided to include these studies , but to perform sensitivity analyses for the primary outcome , as detailed in the statistical section below .", "label": "", "metadata": {}, "score": "67.35597"}
{"text": "The combined sample sizes for the major variables of interest are sufficient to provide statistical power and conclusive data on the safety and efficacy of beta - blockers in HF patients .", "label": "", "metadata": {}, "score": "67.421684"}
{"text": "Cost - effectiveness results .Tables 5 - 7 show the difference in costs , life years , and QALYs by group for the base case .", "label": "", "metadata": {}, "score": "67.433685"}
{"text": "Although the percentage of eligible patients prescribed beta - blockers increased between the first and second Euro Heart Failure surveys , a substantial number of patients remain untreated or receive sub - maximal therapy [ 5 , 6 ] .", "label": "", "metadata": {}, "score": "67.587006"}
{"text": "All 3 studies had patients engaged in supervised training during the early phases .The differences between studies may be due to adherence during the early stages or differences in baseline characteristics , including \u03b2 - blocker use .", "label": "", "metadata": {}, "score": "67.593475"}
{"text": "It does not therefore preserve the randomization planned in the original trial design .Recurrent event analyses are potentially biased by informative censoring due to different mortality rates in the treatment groups .", "label": "", "metadata": {}, "score": "67.661194"}
{"text": "Whether \u03b2 - blocker therapy should be continued or withdrawn during hospitalization for decompensated HF has not been well studied in a broad cohort of patients .", "label": "", "metadata": {}, "score": "67.70892"}
{"text": "As reflected by the interaction P values , there was no significant interaction of exercise training with any of the factors defining these subgroups ; that is , the overall study result was consistent among the various subgroups .", "label": "", "metadata": {}, "score": "67.71417"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Objectives .The objective of this study was to assess the usefulness of each type of strain for left ventricular ( LV ) dyssynchrony assessment and its predictive value for a positive response after cardiac resynchronization therapy ( CRT ) .", "label": "", "metadata": {}, "score": "67.8125"}
{"text": "Conclusion We have demonstrated in a large European population of patients with mild / moderate heart failure that global indi- cators of adherence to the ESC guidelines are associated with decreased rates of heart failure and CV hospitalization and delayed time to rehospitalization .", "label": "", "metadata": {}, "score": "67.82968"}
{"text": "Battery life .On the basis of product specifications , we assumed that batteries were replaced for surviving patients in the CRT - P group every 6 years , and every 7 years in the CRT - ICD group .", "label": "", "metadata": {}, "score": "67.83704"}
{"text": "Conversely , increasing battery life to 8 years reduced the cost per QALY for this comparison to \u20ac 43506 .Model validity .In Table 9 , we assessed the internal validity of the model output by estimating a variety of shorter - term effects to contrast with other models 12 and with the within - trial analysis from CARE - HF trial .", "label": "", "metadata": {}, "score": "67.93256"}
{"text": "Outcomes : Composite endpoint of death from any cause or unplanned hospitalization for major cardiovascular event .Secondary outcomes include death from any cause .Main results .", "label": "", "metadata": {}, "score": "68.02922"}
{"text": "The system measures the resistivity of each lung using optimization methods and transmits the measurements via a modem to a call center .Preliminary results show that the measured resistivity values among healthy young patients are consistent and reproducible within 48 hours .", "label": "", "metadata": {}, "score": "68.15164"}
{"text": "All other trials were funded by pharmaceutical companies .Authors ' contributions .DK participated in the design of the study , manages the collaborative group and performs data management and statistical analysis .", "label": "", "metadata": {}, "score": "68.1942"}
{"text": "The aims of the Collaborative Group are to reduce the burden of morbidity and mortality in heart failure patients and provide clinicians and healthcare agencies with clear guidance on which patients will benefit from beta - blocker therapy .", "label": "", "metadata": {}, "score": "68.23343"}
{"text": "SENIORS : .Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure Study .US - HF : .", "label": "", "metadata": {}, "score": "68.240746"}
{"text": "The primary end point was a composite of all - cause mortality or all - cause hospitalization .Secondary end points included all - cause mortality , the composite of cardiovascular mortality or cardiovascular hospitalization , and the composite of cardiovascular mortality or heart failure hospitalization .", "label": "", "metadata": {}, "score": "68.25038"}
{"text": "Capomolla S , Febo O , Ceresa M et al .Cost / utility ratio in chronic heart failure : comparison between heart failure management program deliv- ered by day - hospital and usual care .", "label": "", "metadata": {}, "score": "68.30954"}
{"text": "NYHA I to III .Death or worsening HF .SENIORS .Elderly HF .All - cause mortality or CV hospitalization ; All - cause mortality ; All - cause hospitalization ; NYHA .", "label": "", "metadata": {}, "score": "68.367004"}
{"text": "We have identified 11 large randomized trials of beta - blockers versus placebo in heart failure and plan to meta - analyze the data on an individual patient level .", "label": "", "metadata": {}, "score": "68.39317"}
{"text": "Eur J Heart Fail 2001;3:503 - 507 .Asch SM , Kerr EA , Lapuerta P et al .A new approach for measuring quality of care for women with hypertension .", "label": "", "metadata": {}, "score": "68.42727"}
{"text": "PubMed View Article .Brophy JM , Joseph L , Rouleau JL : Beta - blockers in congestive heart failure .A Bayesian meta - analysis .", "label": "", "metadata": {}, "score": "68.43059"}
{"text": "Model description .The model had two components : the short - term representing changes in health status and the costs and consequences of the process of device implantation , and the long - term effects of the device after successful implantation ( Figures 1 and 2 ) .", "label": "", "metadata": {}, "score": "68.46483"}
{"text": "HF - ACTION is the largest multicenter , randomized controlled trial of exercise training in heart failure to date .The size and duration of this trial are sufficient to examine for the first time the effect of exercise training on the combined primary end point of all - cause death or all - cause hospitalization in patients with left ventricular systolic dysfunction .", "label": "", "metadata": {}, "score": "68.58057"}
{"text": "Increased mortality associated with low use of clopidogrel in patients with heart failure and acute myocardial infarction not undergoing percutaneous coronary intervention : a nationwide study .", "label": "", "metadata": {}, "score": "68.6075"}
{"text": "All deaths were reviewed by a blinded adjudication committee and categorized according to prespecified definitions on the basis of a narrative and source documentation .The number and rate of deaths by cause were calculated for each of the component trials and the overall program .", "label": "", "metadata": {}, "score": "68.688385"}
{"text": "Current European and American guidelines give a class I recommendation for the use of beta - blockers in patients with symptomatic systolic HF [ 3 , 4 ] .", "label": "", "metadata": {}, "score": "68.75055"}
{"text": "Flynn KE , Pi\u00f1a IL , Whellan DJ , et al .Effects of exercise training on health status in patients with chronic heart failure : HF - ACTION randomized controlled trial .", "label": "", "metadata": {}, "score": "68.768616"}
{"text": "Flynn KE , Pi\u00f1a IL , Whellan DJ , et al .Effects of exercise training on health status in patients with chronic heart failure : HF - ACTION randomized controlled trial .", "label": "", "metadata": {}, "score": "68.768616"}
{"text": "Interventions Usual care plus aerobic exercise training , consisting of 36 supervised sessions followed by home - based training , or usual care alone .Main Outcome Measures Composite primary end point of all - cause mortality or hospitalization and prespecified secondary end points of all - cause mortality , cardiovascular mortality or cardiovascular hospitalization , and cardiovascular mortality or heart failure hospitalization .", "label": "", "metadata": {}, "score": "68.81854"}
{"text": "The reasons for this are multi - factorial and include a long entrenched belief that starting beta - blockers in HF may make symptoms worse or that beta - blockers should only be commenced in specialized clinics .", "label": "", "metadata": {}, "score": "68.910904"}
{"text": "Background Depression is widely recognized as a risk factor in patients with coronary heart disease .However , patients with heart failure ( HF ) have been less frequently studied , and the effect of depression on prognosis , independent of disease severity , is uncertain .", "label": "", "metadata": {}, "score": "68.91464"}
{"text": "Patients with a QRS interval of 120 - 149 ms were required to meet two of three additional criteria for dyssynchrony : an aortic pre - ejection delay of more than 140 ms , an interventricular mechanical delay of more than 40 ms , or delayed activation of the posterolateral left ventricular wall .", "label": "", "metadata": {}, "score": "68.932205"}
{"text": "N Engl J Med 1999;341 : 709 - 717 .Granger CB , McMurray JJ , Yusuf S et al .Effects of candesartan in patients with chronic heart failure and reduced left ventricular systolic function intolerant to angiotensin - converting - enzyme inhibitors : the CHARM- Alternative trial .", "label": "", "metadata": {}, "score": "68.96361"}
{"text": "Physicians who complete the CME course and score at least 80 % correct on the quiz are eligible for AMA PRA Category 1 Credit TM .", "label": "", "metadata": {}, "score": "68.996475"}
{"text": "Physicians who complete the CME course and score at least 80 % correct on the quiz are eligible for AMA PRA Category 1 Credit TM .", "label": "", "metadata": {}, "score": "68.996475"}
{"text": "Our results are also consistent with the most recent guidelines from the European Society of Cardiology for the management of HF , 10 which recommend ivabradine for the reduction in risk for HF hospitalization .", "label": "", "metadata": {}, "score": "69.00011"}
{"text": "A number of inclusion criteria were adopted to make the project methodologically sound and technically feasible .All RCTs of beta - blockers versus placebo explicitly reporting mortality as a primary or combination outcome will be included but not head - to - head comparisons with another active agent .", "label": "", "metadata": {}, "score": "69.224884"}
{"text": "Arch Intern Med 2001;1611725- 1730 PubMed Link to Article .Jiang WAlexander JChristopher E et al .Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure .", "label": "", "metadata": {}, "score": "69.23981"}
{"text": "Analyses by cohort age .We modelled patient groups who started at age 55 , 60 , 70 , and 75 ( Table 8 , Figure 5 ) .", "label": "", "metadata": {}, "score": "69.26518"}
{"text": "doi:10.1016/j.ahj.2011.08.003 .Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure .The SOLVD Investigators .", "label": "", "metadata": {}, "score": "69.27583"}
{"text": "The level of missing data on home exercise makes adherence in the exercise training group difficult to quantify .Some safety end points were measured only in the exercise training group and thus have no within - trial comparator group .", "label": "", "metadata": {}, "score": "69.299614"}
{"text": "Bristow MR , Saxon LA , Boehmer J , et al ; Comparison of Medical Therapy , Pacing , and Defibrillation in Heart Failure ( COMPANION )", "label": "", "metadata": {}, "score": "69.30146"}
{"text": "Bristow MR , Saxon LA , Boehmer J , et al ; Comparison of Medical Therapy , Pacing , and Defibrillation in Heart Failure ( COMPANION )", "label": "", "metadata": {}, "score": "69.30146"}
{"text": "Utility weights were combined with life - years to estimate QALYs .Estimating time to sudden death .Estimates of the time to sudden death were based on the Kaplan - Meier survival curve extrapolated using a Weibull distribution from the CARE - HF trial ( Table 3 ) .", "label": "", "metadata": {}, "score": "69.322266"}
{"text": "There is a need to develop further quality improvement programmes in this condition .KEYWORDS Guidelines ; Chronic heart failure ; Care indicators ; Outcome Introduction Chronic heart failure ( CHF ) is a condition characterized by unpleasant symptoms , high mortality , and recurrent and lengthy hospitalizations .", "label": "", "metadata": {}, "score": "69.34109"}
{"text": "Analysis of the effect of the 2 higher doses of etanercept on the combined outcome of death or hospitalization due to chronic heart failure from the 2 studies was also planned ( RENEWAL ) .", "label": "", "metadata": {}, "score": "69.36382"}
{"text": "At follow - up , 88 patients ( 55 % ) were classified as responders .Conclusions .Speckle tracking RS analysis constitutes the best method to identify potential responders to CRT .", "label": "", "metadata": {}, "score": "69.36445"}
{"text": "There is some evidence that antidepressant drugs are associated with reduced mortality after acute myocardial infarction ( MI ) 11 and with improved cardiac function and fewer adverse events in patients with acute coronary syndromes .", "label": "", "metadata": {}, "score": "69.37637"}
{"text": "Remme WJ , Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure .Eur Heart J 2001;22:1527 - 1560 .Komajda M , Follath F , Swedberg K et al .", "label": "", "metadata": {}, "score": "69.43326"}
{"text": "Costs of care will be derived from simple drivers like hospital length of stay , medications and other treatments and a cost effectiveness analysis will be carried out based on cost per event avoided ( for example , death or hospital admission ) .", "label": "", "metadata": {}, "score": "69.47749"}
{"text": "The base case analysis used 10 000 individual life - time simulations assuming a battery life of 6 years for CRT - P and 7 years for CRT - ICD .", "label": "", "metadata": {}, "score": "69.48451"}
{"text": "In this study , 95 % of patients without a contraindication or intolerance to \u03b2 - blockers or ACE inhibitors received optimal heart failure therapy , defined as a \u03b2 - blocker and either an ACE inhibitor or an angiotensin II receptor blocker .", "label": "", "metadata": {}, "score": "69.484726"}
{"text": "\" [ Show abstract ] [ Hide abstract ] ABSTRACT : Background The role of cardiac natriuretic peptides in the management of patients with chronic heart failure ( HF ) remains uncertain .", "label": "", "metadata": {}, "score": "69.55827"}
{"text": "Dr Gattis Stough received non - trial funding from the study coordinating center .Mr Seils did not receive compensation for his assistance apart from his employment at the study coordinating center .", "label": "", "metadata": {}, "score": "69.57338"}
{"text": "Pitt B , Zannad F , Remme WJ et al .The effect of spironolactone on mor- bidity and mortality in patients with severe heart failure .", "label": "", "metadata": {}, "score": "69.58632"}
{"text": "All data adjusted for prognostic factors at the baseline ( \u03b2 - blocker , New York Heart Association class , left ventricular ejection fraction , ischaemic cause of heart failure , age , systolic blood pressure , heart rate , and creatinine clearance ) .", "label": "", "metadata": {}, "score": "69.62662"}
{"text": "PubMed View Article .Riley RD , Lambert PC , Staessen JA , Wang J , Gueyffier F , Thijs L , Boutitie F : Meta - analysis of continuous outcomes combining individual patient data and aggregate data .", "label": "", "metadata": {}, "score": "69.65964"}
{"text": "In addition to mortality and hospitalization , other cardiovascular adverse events were captured , including worsening heart failure , myocardial infarction , unstable angina , serious adverse arrhythmia , stroke , and transient ischemic attack .", "label": "", "metadata": {}, "score": "69.6802"}
{"text": "N Engl J Med 1996;334:1349 - 1355 .CIBIS II .Investigators and Committees .The Cardiac Insufficiency bisopro- lol Study II ( CIBIS - II ) : a randomised trial .", "label": "", "metadata": {}, "score": "69.75293"}
{"text": "Objective : To assess the impact of supplementing nurse case management with Internet - connected telemonitoring on clinical outcomes in an elderly heart failure ( HF ) population .", "label": "", "metadata": {}, "score": "69.874344"}
{"text": "We identified 56,944 patients with first - time AMI .Patients with HF receiving clopidogrel demonstrated reduced mortality ( hazard ratio , 0.86 ; 95 % confidence interval , 0.78 - 0.95 ) compared with patients with HF not receiving clopidogrel .", "label": "", "metadata": {}, "score": "69.88248"}
{"text": "13 A score of 10 or higher is indicative of clinically significant symptoms of depression .14 The BDI is not an instrument used to diagnose depression but to assess the severity of depressive symptoms .", "label": "", "metadata": {}, "score": "69.90933"}
{"text": "Although tricyclic antidepressants may increase the risk of life - threatening ventricular arrhythmias , 27 in our study , more than 80 % of patients with HF treated for depression were taking a selective serotonin reuptake inhibitor antidepressant .", "label": "", "metadata": {}, "score": "70.001015"}
{"text": "21 , 22 Although the overall significance level was .05 , a significance level of .044 was required at the final analysis due to adjustment for the interim analyses .", "label": "", "metadata": {}, "score": "70.05742"}
{"text": "Uniquely , the BB - HF group has secured access to the individual data for all of these trials , with the participation of key investigators and pharmaceutical companies .", "label": "", "metadata": {}, "score": "70.292076"}
{"text": "A total of 2331 patients were enrolled at 82 participating centers in the United States , Canada , and France .Baseline characteristics of the patients in each randomized group are shown in Table 1 .", "label": "", "metadata": {}, "score": "70.35116"}
{"text": "For analyses , descriptive techniques , 2-tailed Pearson correlation tests , and multiple regression analyses were performed .Results The response- rate of 220 questionnaires was 74 % .", "label": "", "metadata": {}, "score": "70.36803"}
{"text": "Background .Heart failure ( HF ) is a major public health problem with both incidence and prevalence rising rapidly along with associated healthcare costs , estimated to be $ 39.2 billion in the United States and \u00a3 625 million per year in the UK [ 1 , 2 ] .", "label": "", "metadata": {}, "score": "70.38331"}
{"text": "This should encourage development of integrated approaches including nurses , dieticians , generalists , and cardiologists in order to improve the management of CHF in clinical practice .", "label": "", "metadata": {}, "score": "70.386246"}
{"text": "Figures in this Article .Heart failure is a major and increasingly common cardiovascular syndrome , and is the end result of many cardiovascular disorders .", "label": "", "metadata": {}, "score": "70.418175"}
{"text": "Patient recruitment : Adams , Dupree , Waugh , and Gaulden .Funding / Support : This study was supported by grant HL61784 from the National Heart , Lung , and Blood Institute and grant M01-RR-30 from the General Clinical Research Center program , National Center for Research Resources , National Institutes of Health .", "label": "", "metadata": {}, "score": "70.44192"}
{"text": "25 The high prevalence of depression in patients with HF , coupled with its association with poorer outcomes , underscores the need to assess these patients for clinical depression and to develop and evaluate safe and efficacious treatments to ameliorate their depressive symptoms and improve clinical outcomes .", "label": "", "metadata": {}, "score": "70.4972"}
{"text": "This could occur if the additional costs associated with the ICD component are high compared with any additional benefits gained .We developed an economic model populated with data from CARE - HF 7 to evaluate the long - term incremental cost - effectiveness of CRT - P and MT compared with MT alone , on incremental cost per QALY and life - year gained .", "label": "", "metadata": {}, "score": "70.51128"}
{"text": "Heart failure mortality among older medicare beneficiaries : association with left ventricular function evalu- ation and angiotensin - converting enzyme use .South Med J 2003;96 : 124 - 129 .", "label": "", "metadata": {}, "score": "70.58382"}
{"text": "Based on the results of past studies of exercise training , the American College of Cardiology , American Heart Association , European Society of Cardiology , and Canadian Cardiovascular Society have adopted recommendations that physical activity be considered for medically stable patients with systolic dysfunction . 1 , 13 , 14 However , previous studies have been relatively small single - center trials , have not been adequately powered to evaluate mortality and morbidity , and have often lacked an adequate control group .", "label": "", "metadata": {}, "score": "70.67218"}
{"text": "Coats AJ , Adamopoulos S , Radaelli A , et al .Controlled trial of physical training in chronic heart failure : exercise performance , hemodynamics , ventilation , and autonomic function .", "label": "", "metadata": {}, "score": "70.70137"}
{"text": "Coats AJ , Adamopoulos S , Radaelli A , et al .Controlled trial of physical training in chronic heart failure : exercise performance , hemodynamics , ventilation , and autonomic function .", "label": "", "metadata": {}, "score": "70.70137"}
{"text": "The median left ventricular ejection fraction was 25 % , and 51 % of the patients had heart failure with an ischemic etiology .Of patients without an intolerance or contraindication to angiotensin - converting enzyme ( ACE ) inhibitors or \u03b2 - blockers , 95 % were taking a \u03b2 - blocker and either an ACE inhibitor or an angiotensin II receptor blocker .", "label": "", "metadata": {}, "score": "70.81224"}
{"text": "Cox proportional hazards regression analyses were used to examine the effects of depressive symptoms on a combined primary end point of death and hospitalizations because of cardiovascular disease ( hereafter referred to as cardiovascular hospitalization ) during a median follow - up of 3 years .", "label": "", "metadata": {}, "score": "70.81863"}
{"text": "Recruitment , consent procedures , and study design were approved by Western Institutional Review Board ( Olympia , WA , Protocol 20081787 ) .Oral and written consent to telehealth and the study were sought after randomization for THCM .", "label": "", "metadata": {}, "score": "70.90726"}
{"text": "Cost per patient per day for medical care and drug cost were estimated from CARE - HF .7 We assumed the same drug and medical care costs per day for all treatment groups .", "label": "", "metadata": {}, "score": "70.91857"}
{"text": "METHODS .Design .The study design was a prospective , randomized , active controlled study , in which members were allocated to the telehealth system with CM ( THCM ) or to CM alone .", "label": "", "metadata": {}, "score": "70.9357"}
{"text": "Patients were followed up for a median of 3 years .The study sample consisted of 204 patients recruited from HF programs at Duke University Medical Center , Durham , NC , and the University of North Carolina at Chapel Hill from January 19 , 2000 , through December 20 , 2002 .", "label": "", "metadata": {}, "score": "70.945015"}
{"text": "Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management .Can J Cardiol .Dickstein K , Cohen - Solal A , Filippatos G , et al ; Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology ; ESC Committee for Practice Guidelines ; Document Reviewers .", "label": "", "metadata": {}, "score": "71.058655"}
{"text": "Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management .Can J Cardiol .Dickstein K , Cohen - Solal A , Filippatos G , et al ; Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology ; ESC Committee for Practice Guidelines ; Document Reviewers .", "label": "", "metadata": {}, "score": "71.058655"}
{"text": "These findings are consistent with the 33 previous trials and the meta - analyses showing improved outcomes .Corresponding Author : Christopher M. O'Connor , MD , Duke Clinical Research Institute , PO Box 17969 , Durham , NC 27715 ( oconn002@mc.duke.edu ) .", "label": "", "metadata": {}, "score": "71.07762"}
{"text": "Please refer to The JAMA Network 's Privacy Policy for additional information .Sherwood A , Blumenthal JA , Trivedi R , et al .Relationship of Depression to Death or Hospitalization in Patients With Heart Failure .", "label": "", "metadata": {}, "score": "71.20533"}
{"text": "There are also important safety issues to explore , including the risk of adverse events , such as hypotension and bradycardia .Finally , although IPD meta - analyses are considerably more resource - intensive and time - consuming than standard tabular approaches , we believe that only IPD can address the unanswered questions about the use of beta - blockers in HF .", "label": "", "metadata": {}, "score": "71.256134"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Objectives .This study ascertains the relationship between continuation or withdrawal of \u03b2 - blocker therapy and clinical outcomes in patients hospitalized with systolic heart failure ( HF ) .", "label": "", "metadata": {}, "score": "71.31202"}
{"text": "Conclusion Long - term treatment with CRT - P appears cost - effective compared with MT alone .From a life - time perspective , assuming a reasonable life expectancy when receiving effective treatment for heart failure , CRT - ICD may also be considered cost - effective when compared with CRT - P + MT . .", "label": "", "metadata": {}, "score": "71.33052"}
{"text": "J Card Fail 2009 , 15 : 310 - 318 .PubMed View Article .Fauchier L , Grimard C , Pierre B , Nonin E , Gorin L , Rauzy B , Cosnay P , Babuty D , Charbonnier B : Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure .", "label": "", "metadata": {}, "score": "71.43054"}
{"text": "This adjusted analysis will give estimates that are more relevant to individual patients .This is a fixed effect approach and assumes that all trials are estimating a common treatment effect .", "label": "", "metadata": {}, "score": "71.460686"}
{"text": "GAIs were analysed in a multi - variablemodel together with other important clinical , demographic , and co - morbid factors increasing , therefore , the clinical relevance of our results .", "label": "", "metadata": {}, "score": "71.500534"}
{"text": "They were rather hom- ogenous across the six countries .Class adherence indicator was high for ACE - inhibitors ( 85.4 % ) and diuretics ( 83 % ) but was much lower for beta - blockers ( 58 % ) , cardiac glycosides ( 52 % ) , and spironolactone ( 36 % ) with variations across countries .", "label": "", "metadata": {}, "score": "71.50676"}
{"text": "PubMed View Article .Lechat P , Hulot JS , Escolano S , Mallet A , Leizorovicz A , Werhlen - Grandjean M , Pochmalicki G , Dargie H : Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial .", "label": "", "metadata": {}, "score": "71.52668"}
{"text": "In this post hoc analysis , we have explored the effect of continued treatment with ivabradine on recurrent hospitalizations for worsening HF .Methods .Study design .", "label": "", "metadata": {}, "score": "71.75661"}
{"text": "The mean life - time QALYs were 6.75 , 6.06 , and 4.08 and life years was 9.16 , 8.23 , and 6.10 for CRT - ICD + MT , CRT - P + MT , and MT , respectively .", "label": "", "metadata": {}, "score": "71.811325"}
{"text": "N Engl J Med .Konstam MA , Gheorghiade M , Burnett JC Jr , et al ; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan ( EVEREST ) Investigators .", "label": "", "metadata": {}, "score": "71.85014"}
{"text": "N Engl J Med .Konstam MA , Gheorghiade M , Burnett JC Jr , et al ; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan ( EVEREST ) Investigators .", "label": "", "metadata": {}, "score": "71.85014"}
{"text": "Exclusion criteria were as follows : pacemaker dependency , uncontrolled hypertension , MI , percutaneous coronary intervention , or coronary artery bypass grafting within the last 3 months .", "label": "", "metadata": {}, "score": "71.87238"}
{"text": "Management of heart failure in primary care ( the IMPROVEMENT of Heart Failure Programme ) : an international survey .Lancet 2002;360:1631 - 1639 .Komajda M , Bouhour JB , Amouyel P et al .", "label": "", "metadata": {}, "score": "71.96182"}
{"text": "IRR , incidence rate ratio .CI , confidence interval .Hospitalizations ( HF and all cause ) are expressed per patient for all patients and for patients actually hospitalized in Table 3 .", "label": "", "metadata": {}, "score": "71.974014"}
{"text": "\"Dose adjustment is generally based on the clinical assessment of the patient and altering pharmacological treatment based on the status of the patient .However , the clinically guided up - titration approach has been reported to be suboptimal in achieving target doses of evidenced - based therapies [ 58 ] [ 59 ] [ 60].", "label": "", "metadata": {}, "score": "72.08557"}
{"text": "Structure of long - term model ( NYHA class I ) .The structure of the model for other NYHA classes was identical but with different transition probabilities and risk of unplanned hospitalization .", "label": "", "metadata": {}, "score": "72.10679"}
{"text": "3 Depression is associated with a substantially increased risk of developing HF in individuals at risk 4 and has been associated with adverse outcomes in patients with established HF .", "label": "", "metadata": {}, "score": "72.19472"}
{"text": "Eur J Heart Fail 2006 , 8 : 539 - 546 .PubMed View Article .McAlister FA , Wiebe N , Ezekowitz JA , Leung AA , Armstrong PW : Meta - analysis : beta - blocker dose , heart rate reduction , and death in patients with heart failure .", "label": "", "metadata": {}, "score": "72.28606"}
{"text": "For example , in the Enhancing Recovery in Coronary Heart Disease study , patients with a recent MI who received antidepressant medication had improved survival compared with similar patients not receiving medication .", "label": "", "metadata": {}, "score": "72.28973"}
{"text": "It will be reviewed by JAMA Internal Medicine editors .You will be notified when your comment has been published .Comments should not exceed 500 words of text and 10 references .", "label": "", "metadata": {}, "score": "72.31873"}
{"text": "In these calculations , missing values of minutes per week were conservatively assumed to be no exercise .Overall , the performance of exercise training was well tolerated and safe .", "label": "", "metadata": {}, "score": "72.37369"}
{"text": "There is a need to develop further quality improvement programmes in this condition .Full - text .We investigated the consequences of adherence to care by cardiologists on the rate of CHF and cardiovascular ( CV ) hospitalizations and time to CV hospitalization .", "label": "", "metadata": {}, "score": "72.61139"}
{"text": "CV and CHF hospitalization are significantly lower in groups with a better adherence score .Similar trends were not seen for GAI5 ( data not shown ) suggesting that the indi- cator based on robust evidence was more strongly associ- ated with the hospitalization rates .", "label": "", "metadata": {}, "score": "72.63094"}
{"text": "Jiang WAlexander JChristopher E et al .Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure .Arch Intern Med 2001;1611849- 1856 PubMed Link to Article .", "label": "", "metadata": {}, "score": "72.64027"}
{"text": "Global adherence indicator GAI3 was an independent predictor of time to CV hospitalization in a multi - variable model together with NYHA Class , history of CHF hospitalization , ischaemic aetiology , diabetes mellitus , and hypertension .", "label": "", "metadata": {}, "score": "72.66504"}
{"text": "Global adherence indicator GAI3 was an independent predictor of time to CV hospitalization in a multi - variable model together with NYHA Class , history of CHF hospitalization , ischaemic aetiology , diabetes mellitus , and hypertension .", "label": "", "metadata": {}, "score": "72.66504"}
{"text": "The aim was to examine the relationship between quality of care and outcomes and not to interpret the significance of other variables in the multi- variable model .", "label": "", "metadata": {}, "score": "72.69331"}
{"text": "Eur J Heart Fail 2008 ; 10 : 933 - 989 .doi:10.1016/j.ejheart.2008.08.005 . . .Days alive and out of hospital and the patient journey in patients with heart failure : insights from the candesartan in heart failure : assessment of reduction in mortality and morbidity ( CHARM ) program .", "label": "", "metadata": {}, "score": "72.77237"}
{"text": "The total - time approach includes the treatment effect on previous hospitalizations in the evaluation of the effect on a recurrent hospitalization ( thus providing an effect that depends on the effect on previous hospitalizations ) .", "label": "", "metadata": {}, "score": "72.79845"}
{"text": "doi:10.1093/eurheartj / ehl016 . . .Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure : results from the Comparison of Medical Therapy , Pacing and Defibrillation in Heart Failure ( COMPANION ) trial .", "label": "", "metadata": {}, "score": "72.8401"}
{"text": "Am J Cardiol 2005 , 95 : 955 - 959 .View Article .Eur J Heart Fail 2009 , 11 : 872 - 880 .", "label": "", "metadata": {}, "score": "72.90107"}
{"text": "Cost effectiveness of cardiac resynchronization therapy in the comparison of medical therapy , pacing and defibrillation in heart failure ( COMPANION ) trial .J Am Coll Cardiol 2005 ; 46 : 2311 - 2321 .", "label": "", "metadata": {}, "score": "72.95959"}
{"text": "Discussion .Despite a wealth of information identifying the overall benefits of beta - blockers in HF for morbidity and mortality , prescription rates remain sub - optimal with consequence for both patients and healthcare providers .", "label": "", "metadata": {}, "score": "73.00966"}
{"text": "PubMed View Article .Haas SJ , Vos T , Gilbert RE , Krum H : Are beta - blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure ?", "label": "", "metadata": {}, "score": "73.02037"}
{"text": "The unexpected association of antidepressant medications with worse clinical outcome suggests that patients with HF requiring an antidepressant medication may need to be monitored more closely .", "label": "", "metadata": {}, "score": "73.04436"}
{"text": "Common issues covered included health education , safety and emergency measures , medication regimen , and care coordination needs .Telehealth Monitoring With Case Management Group .", "label": "", "metadata": {}, "score": "73.082245"}
{"text": "PubMed View Article .Ghali JK , Pina IL , Gottlieb SS , Deedwania PC , Wikstrand JC , Group M - HS : Metoprolol CR / XL in female patients with heart failure : analysis of the experience in Metoprolol Extended - Release Randomized Intervention Trial in Heart Failure ( MERIT - HF ) .", "label": "", "metadata": {}, "score": "73.09375"}
{"text": "All - cause mortality ; Need for transplantation ; exercise capacity ; NYHA , QoL .12 % metoprolol , 16 % placebo / .All - cause mortality ; Bisoprolol tolerability ( based on NYHA and adverse events ) .", "label": "", "metadata": {}, "score": "73.165405"}
{"text": "Pocock SJ , Assmann SE , Enos LE , Kasten LE .Subgroup analysis , covariate adjustment and baseline comparisons in clinical trial reporting : current practice and problems .", "label": "", "metadata": {}, "score": "73.18204"}
{"text": "Pocock SJ , Assmann SE , Enos LE , Kasten LE .Subgroup analysis , covariate adjustment and baseline comparisons in clinical trial reporting : current practice and problems .", "label": "", "metadata": {}, "score": "73.18204"}
{"text": "Multiple imputation for missing data will be used where appropriate as a sensitivity analysis .Dichotomous outcomes will be combined using an inverse variance meta - analysis .", "label": "", "metadata": {}, "score": "73.22432"}
{"text": "Eur Heart J 2012 .doi:10.1093/eurheartJ / ehs104 . . .Rationale and design of a randomized , double - blind , placebo - controlled outcome trial of ivabradine in chronic heart failure : the Systolic Heart Failure Treatment with the I(f)Inhibitor Ivabradine Trial ( SHIFT ) .", "label": "", "metadata": {}, "score": "73.24405"}
{"text": "Although rest was traditionally recommended for patients with heart failure , over the past 2 decades it has been recognized that physical deconditioning may play a key role in the progression of symptoms and poor outcomes .", "label": "", "metadata": {}, "score": "73.3015"}
{"text": "Baseline medications are given in Table 2 .A total of 69 % of patients were taking an ACE - inhibitor , 87 % either an ACE- inhibitor or an angiotensin type - II receptor blocker , 53 % a beta - blocker , 79 % a diuretic agent , 41 % a cardiac glycoside , and 28 % spironolactone .", "label": "", "metadata": {}, "score": "73.34796"}
{"text": "Written informed consent was obtained from all participants before the study .Clinical information and medical history were obtained from medical records .Current medications were documented as medications being taken at the time of baseline assessments and included both cardiac and psychotropic medications .", "label": "", "metadata": {}, "score": "73.45147"}
{"text": "doi:10.1093/eurjhf / hfp154 . . .ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 .The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology .", "label": "", "metadata": {}, "score": "73.45796"}
{"text": "PubMed View Article .Ghali JK , Krause - Steinrauf HJ , Adams KF , Khan SS , Rosenberg YD , Yancy CW , Young JB , Goldman S , Peberdy MA , Lindenfeld J : Gender differences in advanced heart failure : insights from the BEST study .", "label": "", "metadata": {}, "score": "73.57341"}
{"text": "Aetna Medicare Advantage members with medical and pharmacy benefits were identified through analysis of claims and eligibility information .Exclusion criteria included claims or utilization records indicating a terminal condition , end - stage renal disease , dementia , use of a ventricular assist device , active listing for cardiac transplantation , completed heart transplant , or requirement for chronic or ongoing intravenous HF medication .", "label": "", "metadata": {}, "score": "73.63457"}
{"text": "PubMed View Article .Baumhakel M , Muller U , Bohm M : Influence of gender of physicians and patients on guideline - recommended treatment of chronic heart failure in a cross - sectional study .", "label": "", "metadata": {}, "score": "73.72667"}
{"text": "This trial also highlights the importance of introducing finer selection tools , such as echocardiographic markers of cardiac dyssynchrony , which may in part be responsible for the impressive results of this trial by selecting responders to CR .", "label": "", "metadata": {}, "score": "73.7403"}
{"text": "BMJ .Smart N , Marwick TH .Exercise training for patients with heart failure : a systematic review of factors that improve mortality and morbidity .", "label": "", "metadata": {}, "score": "73.74803"}
{"text": "BMJ .Smart N , Marwick TH .Exercise training for patients with heart failure : a systematic review of factors that improve mortality and morbidity .", "label": "", "metadata": {}, "score": "73.74803"}
{"text": "Part 2 : treatment .The study group of diagnosis of the Working Group on Heart Failure of the European Society of Cardiology .Eur Heart J 2003;24:464 - 474 .", "label": "", "metadata": {}, "score": "73.89629"}
{"text": "Inclusion criteria were ( i ) age ?A target recruitment of 250 patients was planned in each country .Thus , total target recruitment was 1500 patients .", "label": "", "metadata": {}, "score": "73.98589"}
{"text": "For CRT - ICD + MT vs. CRT- P + MT , the incremental cost is \u20ac 33 354 , the QALY score is 0.70 , and the life years gained is 0.93 .", "label": "", "metadata": {}, "score": "74.05081"}
{"text": "Analyze the influence of important pre - randomization patient characteristics on the clinical effects of beta - blockers , including age , diabetes , gender , ejection fraction , renal function , atrial fibrillation and the etiology of HF .", "label": "", "metadata": {}, "score": "74.079216"}
{"text": "At present , the main measure for monitoring the level of pulmonary edema in telemedicine systems is weight , which is not a reliable indicator .", "label": "", "metadata": {}, "score": "74.079666"}
{"text": "( carvedilol ) .NYHA III or IV . zero lost .CAPRICORN .Left ventricular dysfunction post - MI .3 to 21 days post - MI ; .", "label": "", "metadata": {}, "score": "74.15027"}
{"text": "McKelvie RS .Exercise training in patients with heart failure : clinical outcomes , safety , and indications .Heart Fail Rev .Piepoli MF , Davos C , Francis DP , Coats AJ.ExTraMATCH Collaborative .", "label": "", "metadata": {}, "score": "74.174286"}
{"text": "McKelvie RS .Exercise training in patients with heart failure : clinical outcomes , safety , and indications .Heart Fail Rev .Piepoli MF , Davos C , Francis DP , Coats AJ.ExTraMATCH Collaborative .", "label": "", "metadata": {}, "score": "74.174286"}
{"text": "18 This parameter was compared between treatment groups by analysis of covariance , adjusted for potential follow - up , to produce an estimate of the mean difference between treatment groups , as well as associated 95 % CI and P- values .", "label": "", "metadata": {}, "score": "74.203766"}
{"text": "PubMed View Article .Lancet 2003 , 362 : 14 - 21 .PubMed View Article .CIBIS Investigators and Committees : A randomized trial of beta - blockade in heart failure .", "label": "", "metadata": {}, "score": "74.23489"}
{"text": "placebo / .NYHA II or III . zero lost .( carvedilol ) .CIBIS II .Symptomatic HF .15 % bisoprolol , 15 % placebo / .", "label": "", "metadata": {}, "score": "74.26866"}
{"text": "Reduced device cost and increased device longevity both increase the cost - effectiveness of CRT - ICD .There are a number of limitations to our analysis .", "label": "", "metadata": {}, "score": "74.28542"}
{"text": "Exercise was initiated at 15 to 30 minutes per session at a heart rate corresponding to 60 % of heart rate reserve ( maximal heart rate on cardiopulmonary exercise test minus resting heart rate ) .", "label": "", "metadata": {}, "score": "74.31906"}
{"text": "Akosah KO , Schaper AM , Havlik P et al .Improving care for patients with chronic heart failure in the community .The importance of a disease man- agement program .", "label": "", "metadata": {}, "score": "74.48775"}
{"text": "Circulation 1994 , 90 : 1765 - 1773 .View Article .CIBIS Investigators and Committees : The Cardiac Insufficiency Bisoprolol Study II ( CIBIS - II ) : a randomised trial .", "label": "", "metadata": {}, "score": "74.61882"}
{"text": "Siscovick DS , Weiss NS , Fletcher RH , Lasky T. The incidence of primary cardiac arrest during vigorous exercise .N Engl J Med .", "label": "", "metadata": {}, "score": "74.73014"}
{"text": "Siscovick DS , Weiss NS , Fletcher RH , Lasky T. The incidence of primary cardiac arrest during vigorous exercise .N Engl J Med .", "label": "", "metadata": {}, "score": "74.73014"}
{"text": "Objective To test the efficacy and safety of exercise training among patients with heart failure .Design , Setting , and Patients Multicenter , randomized controlled trial of 2331 medically stable outpatients with heart failure and reduced ejection fraction .", "label": "", "metadata": {}, "score": "74.897095"}
{"text": "Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure : HF - ACTION Randomized Controlled Trial FREE .Context Guidelines recommend that exercise training be considered for medically stable outpatients with heart failure .", "label": "", "metadata": {}, "score": "74.97953"}
{"text": "Methodology / Principal Findings MEDLINE , Cochrane , ISI Web of Science and SCOPUS databases were searched for articles reporting natriuretic peptide - guided therapy in HF until August 2012 .", "label": "", "metadata": {}, "score": "75.05676"}
{"text": "At the baseline clinic visit prior to randomization , demographics , socioeconomic status , past medical history , current medications , a physical examination , and the most recent laboratory tests were obtained .", "label": "", "metadata": {}, "score": "75.12807"}
{"text": "Aims We explored the effect of treatment with ivabradine , a pure heart rate - slowing agent , on recurrent hospitalizations for worsening heart failure ( HF ) in the SHIFT trial .", "label": "", "metadata": {}, "score": "75.14865"}
{"text": "Specifically , we will include all randomized patients with outcome data .Primary analysis .The primary and major secondary outcome will be analyzed using a stratified Cox regression model [ 23 ] , with studies as strata .", "label": "", "metadata": {}, "score": "75.18431"}
{"text": "Based on data elicited from the physical activity questionnaire , the median time spent walking at baseline was 40 minutes per week in the usual care group vs 45 minutes per week in the exercise training group .", "label": "", "metadata": {}, "score": "75.19263"}
{"text": "They also answered questions about adherence and their health regimen through their use of the HGS .Telehealth System Description .The Intel HGS is a US Food and Drug Administration - approved system comprising a touch screen , a remote patient management unit placed in the member 's home , and a case manager user interface accessed via secure Internet link through a broadband connection .", "label": "", "metadata": {}, "score": "75.20506"}
{"text": "Abdel - Wahab M , Saad M , Kynast J , et al .Comparison of hospital mortality with intra - aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction .", "label": "", "metadata": {}, "score": "75.23968"}
{"text": "The influence of age and ejection fraction on the effects of beta - blockers will be explored as continuous variables and as clinically relevant categories for other variables .", "label": "", "metadata": {}, "score": "75.28781"}
{"text": "Kop WJGottdiener JSTangen CM et al .Am J Cardiol 2002;89419- 424 PubMed Link to Article .Sherwood AHinderliter ALWatkins LLWaugh RABlumenthal JA Impaired endothelial function in coronary heart disease patients with depressive symptomatology .", "label": "", "metadata": {}, "score": "75.30588"}
{"text": "Kop WJGottdiener JSTangen CM et al .Am J Cardiol 2002;89419- 424 PubMed Link to Article .Sherwood AHinderliter ALWatkins LLWaugh RABlumenthal JA Impaired endothelial function in coronary heart disease patients with depressive symptomatology .", "label": "", "metadata": {}, "score": "75.30588"}
{"text": "Because only a subset of those who were randomized consented and participated , the strategies were evaluated as - treated rather than by intention - to - treat , with multivariate adjustment in logistic regression models for confounding introduced by postrandomization exclusions .", "label": "", "metadata": {}, "score": "75.41029"}
{"text": "Model validation .We validated the model using the observed results of CARE - HF and the published results from COMPANION .Results .Survival .", "label": "", "metadata": {}, "score": "75.44314"}
{"text": "There were 971 male ( 69 % ) and 439 female ( 31 % ) sub- jects with no significant difference across countries .Mean age was 68.6 years [ standard deviation ( SD ) , 10.4].", "label": "", "metadata": {}, "score": "75.45841"}
{"text": "Conclusions / Significance Use of cardiac peptides to guide pharmacologic therapy significantly reduces mortality and HF related hospitalization in patients with chronic HF .In particular , NT - proBNP - guided therapy reduced all - cause mortality and HF - related hospitalization but not all - cause hospitalization , whereas BNP - guided therapy did not significantly reduce both mortality and morbidity . \"", "label": "", "metadata": {}, "score": "75.47281"}
{"text": "Conclusions .Clopidogrel was associated with reduced mortality in patients with HF who do not undergo PCI after their first - time AMI , whereas this association was not apparent in patients without HF .", "label": "", "metadata": {}, "score": "75.50534"}
{"text": "Hazard ratios and corresponding 95 % confidence intervals will be presented , along with the corresponding P -value .Secondary / subgroup analyses .The secondary outcomes will be analyzed in the same manner as the primary outcome .", "label": "", "metadata": {}, "score": "75.51925"}
{"text": "Depression may contribute to poor prognosis in patients with HF via adverse effects on health behaviors , including smoking , physical inactivity , and nonadherence to prescribed treatment plans .", "label": "", "metadata": {}, "score": "75.67598"}
{"text": "Therefore , no adjustments were made for multiple comparisons .All tests were two - sided .Graphical methods were used to assess model assumptions and all were satisfied .", "label": "", "metadata": {}, "score": "75.70351"}
{"text": "Dosage error in article text PubMed View Article .Circulation 2009 , 119 : 1977 - 2016 .PubMed View Article .Eur Heart J 2003 , 24 : 464 - 474 .", "label": "", "metadata": {}, "score": "75.74803"}
{"text": "Finally , data on hospitalization burden may be influenced by differences between health - care systems in different countries .Conclusion .Our findings support the importance of heart rate reduction with ivabradine , when undertaken on a background of guideline - based therapy , for improving clinical outcomes in HF .", "label": "", "metadata": {}, "score": "75.78739"}
{"text": "Access to the PDF is only available via article purchase .[ Show abstract ] [ Hide abstract ] ABSTRACT : Objectives .We studied the association of clopidogrel with mortality in acute myocardial infarction ( AMI ) patients with heart failure ( HF ) not receiving percutaneous coronary intervention ( PCI ) .", "label": "", "metadata": {}, "score": "75.80299"}
{"text": "\" [ Show abstract ] [ Hide abstract ] ABSTRACT : Background Clinical Decision Support Systems ( CDSSs ) can support guideline adherence in heart failure ( HF ) patients .", "label": "", "metadata": {}, "score": "75.84685"}
{"text": "A full list of collaborators is presented in Appendix A. Two meetings of the collaborative group in November 2008 and August 2010 were used to define our objectives , establish inclusion criteria and develop the primary and secondary objectives .", "label": "", "metadata": {}, "score": "75.99823"}
{"text": "Please refer to The JAMA Network 's Privacy Policy for additional information . O'Connor CM , Whellan DJ , Lee KL , et al .Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure : HF - ACTION Randomized Controlled Trial .", "label": "", "metadata": {}, "score": "76.06894"}
{"text": "For each of the five therapeutic classes of interest , we computed a class adherence indicator defined as the proportion of patients whose physicians prescribed according to the guidelines .", "label": "", "metadata": {}, "score": "76.112885"}
{"text": "Conclusions In the protocol - specified primary analysis , exercise training resulted in nonsignificant reductions in the primary end point of all - cause mortality or hospitalization and in key secondary clinical end points .", "label": "", "metadata": {}, "score": "76.15139"}
{"text": "During these calls , as well as during the supervised training sessions and at follow - up clinic visits , adherence to the exercise training regimen was promoted by study personnel .", "label": "", "metadata": {}, "score": "76.15927"}
{"text": "Methods .The Beta - blockers in Heart Failure Collaborative Group ( BB - HF ) .The BB - HF group is a collaborative , multinational effort to combine individual data from the major randomized controlled trials ( RCTs ) investigating the use of beta - blockers in chronic HF .", "label": "", "metadata": {}, "score": "76.17114"}
{"text": "We estimated monthly transition probability on the basis of the 5 month data by matrix algebra on the assumption of a constant Markov chain property during this period ( Table 1 ) .", "label": "", "metadata": {}, "score": "76.21373"}
{"text": "Organised program to initiate lifesavingtreatmentinhospitalized ( OPTIMIZE - HF ) : rationale and design .Am Heart J 2004;148:43 - 51 .Data provided are for informational purposes only .", "label": "", "metadata": {}, "score": "76.21617"}
{"text": "J Am Coll Cardiol 2001;38199- 205 PubMed Link to Article .Gallagher MJMcCullough PA The emerging role of natriuretic peptides in the diagnosis and treatment of decompensated heart failure .", "label": "", "metadata": {}, "score": "76.29452"}
{"text": "It was homogenous across countries except in UK where it was 155 days because of the late start of recruitment in this country .There were 1421 patients included in the MAHLER study , of whom 1410 were evaluable .", "label": "", "metadata": {}, "score": "76.51639"}
{"text": "Of these , 496 patients ( 35 % ) had experienced at least one previous CHF hospitalization .This proportion was higher in Italy ( 44 % ) and in The Netherlands ( 43 % ) than in Spain ( 39 % ) , UK ( 36 % ) , France ( 29 % ) , or Germany ( 21 % ) .", "label": "", "metadata": {}, "score": "76.57393"}
{"text": "Secondary mortality outcomes include death due to acute myocardial infarction ( MI ) , stroke , sudden cardiac death and HF - related death .Other secondary outcomes are non - fatal MI , all - cause hospitalization , cardiovascular hospitalization , HF - related hospitalization and the number and duration of hospital admissions .", "label": "", "metadata": {}, "score": "76.62382"}
{"text": "It retrieves unique information correlated with the amount of fluid in the lungs and transmits the data to a medical call center in order to improve the diagnostics and treatment of congestive heart failure .", "label": "", "metadata": {}, "score": "76.65978"}
{"text": "The proposed meta - analysis will allow a reliable exploration of any interaction on the effect of beta - blockers with age , albeit limited to the populations recruited in the individual studies .", "label": "", "metadata": {}, "score": "76.72688"}
{"text": "PubMed Link to Article .Taylor CBYoungblood MECatellier D et al .Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction .", "label": "", "metadata": {}, "score": "76.752655"}
{"text": "PubMed Link to Article .Taylor CBYoungblood MECatellier D et al .Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction .", "label": "", "metadata": {}, "score": "76.752655"}
{"text": "In the interim , patients with HF requiring antidepressant medication may need to be monitored more closely .Author Contributions : Dr Sherwood had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis .", "label": "", "metadata": {}, "score": "76.75342"}
{"text": "Careful initial evaluation will be performed to ensure completeness of data , and to check consistency of the results of the primary analyses for each trial with published reports .", "label": "", "metadata": {}, "score": "76.91705"}
{"text": "All rights reserved .Tel : \u00fe33 1 4216 3003 ; fax : \u00fe33 1 4216 3020 .Page 2 .The primary objective was to describe the medical management , healthcare resource utilization , and the direct or indirect costs of this condition in each participating country and will be reported elsewhere .", "label": "", "metadata": {}, "score": "77.0786"}
{"text": "Race , quality of care and outcomes of elderly patients hospitalized with heart failure .JAMA 2003;289 : 2517 - 2524 .Fonarow GC , Yancy CW , Chang SF .", "label": "", "metadata": {}, "score": "77.21788"}
{"text": "Figures 4 A and B present the cost - effectiveness acceptability curves for CRT - P + MT and CRT - ICD + MT vs. MT , and CRT - ICD + MT vs. CRT - P + MT respectively .", "label": "", "metadata": {}, "score": "77.3083"}
{"text": "The investigator was then identified by the head of the department of cardiology .The list of investigators is provided in Appendix II .First , it was determined whether , according to the individ- ual patient 's profile , a recommended drug was prescribed .", "label": "", "metadata": {}, "score": "77.355125"}
{"text": "Cardiac - resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure .N Engl J Med .Cleland JG , Daubert JC , Erdmann E , et al ; Cardiac Resynchronization - Heart Failure ( CARE - HF ) Study Investigators .", "label": "", "metadata": {}, "score": "77.401566"}
{"text": "Cardiac - resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure .N Engl J Med .Cleland JG , Daubert JC , Erdmann E , et al ; Cardiac Resynchronization - Heart Failure ( CARE - HF ) Study Investigators .", "label": "", "metadata": {}, "score": "77.401566"}
{"text": "Values are n ( % ) or means \u00b1 SD .ACE , angiotensin - converting enzyme ; ARB , angiotensin receptor blocker ; eGFR , estimated glomerular filtration rate ( Modification in Diet in Renal Disease Formula ) ; NYHA , New York Heart Association .", "label": "", "metadata": {}, "score": "77.42726"}
{"text": "Values are n ( % ) or means \u00b1 SD .ACE , angiotensin - converting enzyme ; ARB , angiotensin receptor blocker ; eGFR , estimated glomerular filtration rate ( Modification in Diet in Renal Disease Formula ) ; NYHA , New York Heart Association .", "label": "", "metadata": {}, "score": "77.42726"}
{"text": "The system was also programmed to ask members about their health status , activities , and medication adherence , and to offer and show educational videos .", "label": "", "metadata": {}, "score": "77.533195"}
{"text": "doi:10.1016/j.jacc.2011.04.024 .Vertical Tabs .Abstract .Aims Cardiac resynchronization therapy ( CRT - P ) is an effective treatment for patients with heart failure and cardiac dyssynchrony with moderate or severe symptoms despite pharmacological therapy .", "label": "", "metadata": {}, "score": "77.559875"}
{"text": "The BB - HF project was investigator initiated .The BB - HF collaborative group extends their thanks to the four pharmaceutical companies that have supported this project .", "label": "", "metadata": {}, "score": "77.56665"}
{"text": "Statistical methods .Baseline characteristics are presented as numbers and percentages for categorical variables and means ( \u00b1SD ) for continuous variables .Baseline characteristics were compared according to the number of hospitalizations for worsening HF during the study ( none , one , two , or three or more ) in pooled treatment groups , using a Kruskal - Wallis test for continuous variables and a \u03c7 2 test for categorical variables .", "label": "", "metadata": {}, "score": "77.76207"}
{"text": "Leizorovicz A , Lechat P , Cucherat M , Bugnard F : Bisoprolol for the treatment of chronic heart failure : a meta - analysis on individual data of two placebo - controlled studies - CIBIS and CIBIS II Cardiac Insufficiency Bisoprolol Study .", "label": "", "metadata": {}, "score": "77.764496"}
{"text": "Influence of beta - blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure : findings from the OPTIMIZE - HF program .J Am Coll Cardiol .", "label": "", "metadata": {}, "score": "77.83717"}
{"text": "Implantation cost included device cost , procedure cost , intravenous medication , and hospital stay ( including ICU and CCU ) .Table 2 summarizes the cost data by different categories .", "label": "", "metadata": {}, "score": "77.85279"}
{"text": "Bettencourt PAzevedo APimenta JFrioes FFerreira SFerreira A N - terminal - pro - brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients .", "label": "", "metadata": {}, "score": "77.925064"}
{"text": "None of the pharmaceutical groups have any role in data analysis or the drafting of manuscripts .Any additional funding received will be stipulated in future publications .", "label": "", "metadata": {}, "score": "77.987915"}
{"text": "von Kanel RMills PJFainman CDimsdale JE Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis : a biobehavioral pathway to coronary artery disease ?", "label": "", "metadata": {}, "score": "78.03727"}
{"text": "von Kanel RMills PJFainman CDimsdale JE Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis : a biobehavioral pathway to coronary artery disease ?", "label": "", "metadata": {}, "score": "78.03727"}
{"text": "The question of whether to implant CRT - P or CRT - ICD remains controversial , and as Jarcho 21 has noted , a definitive trial comparing these treatments may never be conducted .", "label": "", "metadata": {}, "score": "78.075714"}
{"text": "It represents the most common cause for hospitalization among elderly Americans1 and was the nation 's most expensive medical condition to treat in 2005 , costing $ 76 billion .", "label": "", "metadata": {}, "score": "78.1353"}
{"text": "For Cox regression analyses , NT - proBNP and BDI scores were trimmed at the 95th percentiles , NT - proBNP was expressed as NT - proBNP/1000 pg / mL , and age was expressed as age/10 .", "label": "", "metadata": {}, "score": "78.26814"}
{"text": "Metoprolol CR / XL Randomised Intervention Trial in Congestive Heart Failure .MI : .Myocardial infarction .NYHA : .New York Heart Association .", "label": "", "metadata": {}, "score": "78.31485"}
{"text": "Our term ' adherence ' in this study related solely to physicians following guidelines , not to patient compliance or persistence .Owing to the fact that evidence - based benefit on outcome is much stronger for ACE - inhibitors , beta - blockers , and spironolactone than for cardiac glycosides or diuretics , we also calculated a separ- ate GAI on the basis of first three classes ( GAI3 ) .", "label": "", "metadata": {}, "score": "78.31825"}
{"text": "Hunt SA , Abraham WT , Chin MH , et al ; American College of Cardiology ; American Heart Association Task Force on Practice Guidelines ; American College of Chest Physicians ; International Society for Heart and Lung Transplantation ; Heart Rhythm Society .", "label": "", "metadata": {}, "score": "78.36896"}
{"text": "Cardiac resynchronization therapy .Implantable cardioverter defibrillator .Markov model .Individual simulation .Introduction .Heart failure is a common disease and costly in terms of morbidity , mortality , and resources consumed .", "label": "", "metadata": {}, "score": "78.39384"}
{"text": "With time - to - event outcomes , adjustment for strong predictors of the outcome enables the analysis to more specifically compare patients of like risk with like risk and thereby increases the statistical power .", "label": "", "metadata": {}, "score": "78.40042"}
{"text": "Because this study is a post hoc analysis of SHIFT data , the statistical methods employed also were selected post hoc , though they are standard for analyses of this type .", "label": "", "metadata": {}, "score": "78.44968"}
{"text": "PubMed View Article .Waagstein F , Bristow MR , Swedberg K , Camerini F , Fowler MB , Silver MA , Gilbert EM , Johnson MR , Goss FG , Hjalmarson A , Metoprolol in Dilated Cardiomyopathy ( MDC ) Trial Study Group : Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy .", "label": "", "metadata": {}, "score": "78.49045"}
{"text": "Case managers were not directly responsible for patient care , but worked closely with the members , physicians , subspecialty providers , and others to facilitate care to manage the complex cardiac , oncologic , psychiatric , social , other medical , and/or end - of - life needs of the participants .", "label": "", "metadata": {}, "score": "78.53592"}
{"text": "Although blinding for patients and investigators was not possible due to the nature of the exercise training intervention , deaths and cardiovascular hospitalizations for each patient were adjudicated by a clinical end point committee blinded to treatment assignment .", "label": "", "metadata": {}, "score": "78.62194"}
{"text": "CONCLUSIONS : The results of RENEWAL rule out a clinically relevant benefit of etanercept on the rate of death or hospitalization due to chronic heart failure .", "label": "", "metadata": {}, "score": "78.74663"}
{"text": "Use of clopidogrel after AMI is low in patients with HF , despite the fact that clopidogrel is associated with absolute mortality reduction in AMI patients .", "label": "", "metadata": {}, "score": "78.782135"}
{"text": "Blinding of the patients and the research personnel was not possible .More than 50 % of the patients randomized to the usual care group were either somewhat or very dissatisfied with their treatment assignment ; a number of these patients likely crossed over and initiated exercise training .", "label": "", "metadata": {}, "score": "79.01617"}
{"text": "Similarly , for patients starting at age 75 , the ICER rose to \u20ac 73 299 .Battery life .The effect of different battery life for CRT - ICD on the incremental cost per QALY is described in Table 10 .", "label": "", "metadata": {}, "score": "79.0898"}
{"text": "Carney RMBlumenthal JAFreedland KE et al .Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease ( ENRICHD ) study .", "label": "", "metadata": {}, "score": "79.109825"}
{"text": "Carney RMBlumenthal JAFreedland KE et al .Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease ( ENRICHD ) study .", "label": "", "metadata": {}, "score": "79.109825"}
{"text": "JAMA .Narang R , Swedberg K , Cleland JG .What is the ideal study design for evaluation of treatment for heart failure ? insights from trials assessing the effect of ACE inhibitors on exercise capacity .", "label": "", "metadata": {}, "score": "79.18846"}
{"text": "JAMA .Narang R , Swedberg K , Cleland JG .What is the ideal study design for evaluation of treatment for heart failure ? insights from trials assessing the effect of ACE inhibitors on exercise capacity .", "label": "", "metadata": {}, "score": "79.18846"}
{"text": "We adopted a discount rate of 3.5 % annually for costs and benefits .Probabilistic sensitivity analysis .We conducted probabilistic sensitivity analysis across all input values , together with scenario analysis of the assumptions within the model .", "label": "", "metadata": {}, "score": "79.2922"}
{"text": "PubMed View Article .Lee DS , Tu JV , Juurlink DN , Alter DA , Ko DT , Austin PC , Chong A , Stukel TA , Levy D , Laupacis A : Risk - treatment mismatch in the pharmacotherapy of heart failure .", "label": "", "metadata": {}, "score": "79.415276"}
{"text": "At the time of this publication , individual data on 15,922 participants ( representing 10 of the 11 trials ) have been received by the coordinating center , the Clinical Trials and Evaluation Unit , Royal Brompton & Harefield NHS Trust / Imperial College London .", "label": "", "metadata": {}, "score": "79.45387"}
{"text": "Sensitivity analyses were performed on secondary outcomes capping outliers ' results at the 99th percentile ; since no difference was seen , only the raw data are shown .", "label": "", "metadata": {}, "score": "79.5035"}
{"text": "JAMA .Belardinelli R , Georgiou D , Cianci G , Purcaro A. Randomized , controlled trial of long - term moderate exercise training in chronic heart failure : effects on functional capacity , quality of life , and clinical outcome .", "label": "", "metadata": {}, "score": "79.51709"}
{"text": "JAMA .Belardinelli R , Georgiou D , Cianci G , Purcaro A. Randomized , controlled trial of long - term moderate exercise training in chronic heart failure : effects on functional capacity , quality of life , and clinical outcome .", "label": "", "metadata": {}, "score": "79.51709"}
{"text": "Maggioni AP , Sinagra G , Opasisch C et al .Treatment of chronic heart failure with beta - adrenergic blockade beyond controlled clinical trials : the BRING UP experience .", "label": "", "metadata": {}, "score": "79.523445"}
{"text": "CONCLUSIONS : Candesartan reduced sudden death and death from worsening heart failure in patients with symptomatic heart failure , although this reduction was most apparent in patients with systolic dysfunction .", "label": "", "metadata": {}, "score": "79.64484"}
{"text": "Methods and Results .Participants received pioglitazone or glyburide ( \u00b1insulin ) for 6 months in this double - blind , randomized , multicenter study .", "label": "", "metadata": {}, "score": "79.77519"}
{"text": "Patients were randomized from April 2003 through February 2007 within the United States , Canada , and France .The protocol was reviewed and approved by the appropriate institutional review board or ethics committee for each participating center and by the coordinating center 's institutional review board .", "label": "", "metadata": {}, "score": "79.81136"}
{"text": "DGA and NW participated in the design of the study and the statistical analysis .All authors drafted , read and approved the final manuscript .", "label": "", "metadata": {}, "score": "79.837875"}
{"text": "Am Heart J 2003 , 146 : 848 - 853 .PubMed View Article .J Am Coll Cardiol 2009 , 53 : 2150 - 2158 .", "label": "", "metadata": {}, "score": "79.85335"}
{"text": "This paper outlines inclusion criteria , search strategies , outcome measures and planned statistical analyses .Trial registration .Keywords .Electronic supplementary material .The online version of this article ( doi : 10 .", "label": "", "metadata": {}, "score": "79.87683"}
{"text": "Meta - analysis was performed to assess the influence of treatment on outcomes .Sensitivity analysis was performed to test the influence of potential effect modifiers and of each trial included in meta - analysis on results .", "label": "", "metadata": {}, "score": "79.94953"}
{"text": "PubMed View Article .Sheppard R , Behlouli H , Richard H , Pilote L : Effect of gender on treatment , resource utilization , and outcomes in congestive heart failure in Quebec .", "label": "", "metadata": {}, "score": "79.96788"}
{"text": "The impact on outcome of the implementation of European guidelines for the treatment of chronic heart failure ( CHF ) has not been evaluated .We investigated the consequences of adherence to care by cardiologists on the rate of CHF and cardiovascular ( CV ) hospitalizations and time to CV hospitalization .", "label": "", "metadata": {}, "score": "80.19745"}
{"text": "The current cost of heart failure to the National Health Service in the United Kingdom .Eur J Heart Fail 2002;4:361 - 371 .Konstam MA , Rousseau MF , Kronenberg MW et al .", "label": "", "metadata": {}, "score": "80.25042"}
{"text": "Estimates of device longevity for older generation CRT - ICD products were 5 - 6 years , however , current developments in lead technology mean that lower battery consumption is needed to stimulate effectively the chamber with an appropriate safety margin .", "label": "", "metadata": {}, "score": "80.41316"}
{"text": "Glassman AHO'Connor CMCaliff RM et al .Sertraline treatment of major depression in patients with acute MI or unstable angina .JAMA 2002;288701- 709[published correction appears in JAMA .", "label": "", "metadata": {}, "score": "80.44539"}
{"text": "Glassman AHO'Connor CMCaliff RM et al .Sertraline treatment of major depression in patients with acute MI or unstable angina .JAMA 2002;288701- 709[published correction appears in JAMA .", "label": "", "metadata": {}, "score": "80.44539"}
{"text": "PubMed .Shibata MC , Flather MD , Wang D : Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure .", "label": "", "metadata": {}, "score": "80.485176"}
{"text": "( C ) Beta - blockersIF ' NO ' to diagnoses of asthma / COPD THEN guidelines apply .IF Guidelines applies AND patient is on beta - blocker at baseline THEN guidelines are met .", "label": "", "metadata": {}, "score": "80.511536"}
{"text": "Conclusions Both cardiologists and HF - nurses perceived barriers in working with a CDSS in all of the examined constructs .KM has a strong positive correlation with perceived barriers , indicating that increasing knowledge about CDSSs can decrease their barriers .", "label": "", "metadata": {}, "score": "80.517914"}
{"text": "One method that has demonstrated success in improving adherence is the reduction in the frequency of drug administration ( eg , switching from a twice - daily to a once - daily regimen ) .", "label": "", "metadata": {}, "score": "80.63738"}
{"text": "IF Guidelines applies AND patient is on ACE inhibitor or AIIRA at baseline THEN guidelines are met .( B ) DiureticsIF NYHA class II at baseline AND ' YES ' to symptoms of ankle swelling THEN guidelines apply ; ELSE IF NYHA class III or IV at baseline THEN guidelines apply .", "label": "", "metadata": {}, "score": "80.7923"}
{"text": "Ray WAMeredith SThapa PBHall KMurray KT Cyclic antidepressants and the risk of sudden cardiac death .Clin Pharmacol Ther 2004;75234- 241 PubMed Link to Article .", "label": "", "metadata": {}, "score": "80.81079"}
{"text": "The lack of change in exercise testing parameters at 12 months may have been due to an insufficient training stimulus in most patients .A potential cause for the blunted training effect was the high use of \u03b2 - blockers , which have been shown to limit peak oxygen consumption changes in healthy patients .", "label": "", "metadata": {}, "score": "80.94307"}
{"text": "References .Hunt SA , Abraham WT , Chin MH , et al ; American College of Cardiology ; American Heart Association Task Force on Practice Guidelines ; American College of Chest Physicians ; International Society for Heart and Lung Transplantation ; Heart Rhythm Society .", "label": "", "metadata": {}, "score": "80.97866"}
{"text": "View Article .Eur Heart J 2005 , 26 : 215 - 225 .PubMed View Article .Packer M , Bristow MR , Cohn JN , Colucci WS , Fowler MB , Gilbert EM , Shusterman NH , Carvedilol Heart Failure Study Group :", "label": "", "metadata": {}, "score": "81.0379"}
{"text": "Statistical comparisons of the study groups with respect to clinical outcomes were performed according to the intention - to - treat principle .All statistical tests were 2-tailed .", "label": "", "metadata": {}, "score": "81.09376"}
{"text": "Komajda M , Hanon O , Hochadel M , Lopez - Sendon JL , Follath F , Ponikowski P , Harjola V - P , Drexler H , Dickstein K , Tavazzi L , Nieminen M : Contemporary management of octogenarians hospitalized for heart failure in Europe : Euro Heart Failure Survey II .", "label": "", "metadata": {}, "score": "81.19719"}
{"text": "Vaccarino VKasl SVAbramson JKrumholz HM Depressive symptoms and risk of functional decline and death in patients with heart failure .J Am Coll Cardiol 2001;38199- 205 PubMed Link to Article .", "label": "", "metadata": {}, "score": "81.247116"}
{"text": "Curr Heart Fail Rep 2004;1129- 135 PubMed Link to Article .Bettencourt PAzevedo APimenta JFrioes FFerreira SFerreira A N - terminal - pro - brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients .", "label": "", "metadata": {}, "score": "81.24964"}
{"text": "Collaborative Group .Abbreviations .Australia / New Zealand Heart Failure Study .ARB : .Angiotensin receptor blockers .BB - HF : .Beta - Blockers in Heart Failure Collaborative Group .", "label": "", "metadata": {}, "score": "81.30454"}
{"text": "19 , 20 Longer battery life clearly results in an increased cost - effectiveness of CRT - ICD + MT compared with CRT - P + MT , but conversely shorter device life in practice will result in reduced cost - effectiveness .", "label": "", "metadata": {}, "score": "81.33094"}
{"text": "Although carefully collected , accuracy can not be guaranteed .The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .", "label": "", "metadata": {}, "score": "81.40821"}
{"text": "PubMed View Article .Eur Heart J 2008 , 29 : 2388 - 2442 .Erratum in : Eur Heart J 2010 , 12:416 .Dosage error in article text .", "label": "", "metadata": {}, "score": "81.45836"}
{"text": "View Article .Packer M , Coats AJ , Fowler MB , Katus HA , Krum H , Mohacsi P , Rouleau JL , Tendera M , Castaigne A , Roecker EB , Schultz MK , DeMets DL : Effect of carvedilol on survival in severe chronic heart failure .", "label": "", "metadata": {}, "score": "81.46058"}
{"text": "Tudur Smith C , Williamson PR : A comparison of methods for fixed effects meta - analysis of individual patient data with time to event outcomes .", "label": "", "metadata": {}, "score": "81.49159"}
{"text": "Baseline characteristics were expressed as means and percentages , and compared between the 2 groups using X 2 tests and independent t tests .The analysis of the primary outcome was initially conducted according to intention - to - treat for the randomized population .", "label": "", "metadata": {}, "score": "81.495575"}
{"text": "18 Relative risks were expressed as hazard ratios ( HRs ) with 95 % confidence intervals ( CIs ) and were calculated using the Cox proportional hazards model .", "label": "", "metadata": {}, "score": "81.64166"}
{"text": "Gottlieb SSKhatta MFriedmann E et al .The influence of age , gender , and race on the prevalence of depression in heart failure patients .", "label": "", "metadata": {}, "score": "81.64395"}
{"text": "Gottlieb SSKhatta MFriedmann E et al .The influence of age , gender , and race on the prevalence of depression in heart failure patients .", "label": "", "metadata": {}, "score": "81.64395"}
{"text": "MAHLER confirms that a number of patients with symptomatic systolic dysfunction are still not treated or can not be treated with beta - blockers despite a high level of evidence in favour of beneficial effect on morbidity and mortality .", "label": "", "metadata": {}, "score": "81.711555"}
{"text": "PubMed .Am Heart J 2007 , 154 : 109 - 115 .PubMed View Article .Stewart LA , Tierney JF : To IPD or not to IPD ?", "label": "", "metadata": {}, "score": "81.73328"}
{"text": "U.S. N Engl J Med 1996 , 334 : 1349 - 1355 .PubMed View Article .he RESOLVD Investigators : Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study .", "label": "", "metadata": {}, "score": "81.805115"}
{"text": "Important clinical considerations for these applications are discussed to facilitate appropriate implementation in the clinical laboratory .Conclusion Most clinical laboratories should be considering the appropriate implementation of the B - type natriuretic peptide as a diagnostic test to assist in ruling out heart failure .", "label": "", "metadata": {}, "score": "81.91304"}
{"text": "Background .Different echocardiographic techniques have been proposed for assessment of LV dyssynchrony .The novel 2-dimensional ( 2D ) speckle tracking strain analysis technique can provide information on radial strain ( RS ) , circumferential strain ( CS ) , and longitudinal strain ( LS ) .", "label": "", "metadata": {}, "score": "82.00705"}
{"text": "ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 : The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology .", "label": "", "metadata": {}, "score": "82.06138"}
{"text": "View Article .Beta - Blocker Evaluation of Survival Trial Investigators : A trial of the beta - blocker bucindolol in patients with advanced chronic heart failure .", "label": "", "metadata": {}, "score": "82.13426"}
{"text": "Telemonitoring With Case Management for Seniors With Heart Failure .An Internet - based telehealth intervention for elderly heart failure patients found no discernible incremental impact on morbidity or mortality compared with case management alone .", "label": "", "metadata": {}, "score": "82.362366"}
{"text": "Prior to the 1990s , beta - blockers were considered to be contraindicated in HF .With an increased understanding of the pathophysiology of HF , the hypothesis developed that beta - blockers may alleviate inappropriate sympathetic drive , reduce heart rate and allow better cardiac filling .", "label": "", "metadata": {}, "score": "82.41804"}
{"text": "To explore the influence of baseline covariates on the primary and major secondary outcomes , we will develop multivariable models using the Cox proportional hazards approach to develop a risk score .", "label": "", "metadata": {}, "score": "82.47445"}
{"text": "Competing interests .The majority of the collaborative group have received speaker fees , honoraria or grant support from pharmaceutical companies involved in beta - blocker therapies .", "label": "", "metadata": {}, "score": "82.492516"}
{"text": "Cox proportional hazards regression models were used to examine the relationship between baseline characteristics and events ( death and hospitalizations ) during follow - up .", "label": "", "metadata": {}, "score": "82.51456"}
{"text": "Examine the potential economic impact of treatment under a variety of circumstances and different subgroups .i ) .Improve statistical methodology for IPD meta - analysis .", "label": "", "metadata": {}, "score": "82.5173"}
{"text": "Circulation 1995;91999- 1005[published correction appears in Circulation .1998;97:708 ] PubMed Link to Article .Hughes JWWatkins LBlumenthal JAKuhn CSherwood A Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle - aged women .", "label": "", "metadata": {}, "score": "82.58305"}
{"text": "Circulation 1995;91999- 1005[published correction appears in Circulation .1998;97:708 ] PubMed Link to Article .Hughes JWWatkins LBlumenthal JAKuhn CSherwood A Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle - aged women .", "label": "", "metadata": {}, "score": "82.58305"}
{"text": "Previous Presentation : Presented as a late - breaking clinical trial at the American Heart Association Scientific Sessions ; November 11 , 2008 ; New Orleans , Louisiana .", "label": "", "metadata": {}, "score": "82.58559"}
{"text": "Doppler echocardiography was the method of choice for the confirmation of cardiac dys- function in .80 % of patients except for patients of UK .On average , the adherence to ESC guidelines for diagnosis of CHF in the six countries was high with slight variations 1654M. Page 3 . across countries .", "label": "", "metadata": {}, "score": "82.68559"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Primary percutaneous coronary intervention ( PCI ) and intra - aortic balloon pump counterpulsation ( IABP ) are established treatment modalities in acute myocardial infarction complicated by cardiogenic shock .", "label": "", "metadata": {}, "score": "82.748375"}
{"text": "For beta - blockers , surveys show a constant under use both in terms of prescriptions and daily dosage .Here again , the rate of prescription is increased significantly among cardiol- ogists vs. non - cardiologists,11,20and we observed in MAHLER a greater adherence to beta - blocker therapy than in the previous surveys .", "label": "", "metadata": {}, "score": "82.800934"}
{"text": "Pfeffer MA , Swedberg K , Granger CB et al .Effects of candesartan on mortality and morbidity in patients with chronic heart failure : the CHARM - Overall programme .", "label": "", "metadata": {}, "score": "82.83278"}
{"text": "Spironolactone IF NYHA class III or IV at baseline THEN guidelines apply .IF Guidelines applies AND patient is on spironolac- tone at baseline THEN guidelines are met .", "label": "", "metadata": {}, "score": "82.90178"}
{"text": "Probabilities are given for patients on MT receiving a CRT ( \u00b1 ICD ) device and for those receiving MT alone .Efficacy .Effectiveness is expressed as transition probabilities between Markov states .", "label": "", "metadata": {}, "score": "83.00105"}
{"text": "The lack of blinding also may have caused differential attention to patients by the study personnel .However , the investigators attempted to control for the inherent differences in the amount of contact with caregivers by regular telephone contact and follow - up of the patients in both study groups of the trial .", "label": "", "metadata": {}, "score": "83.082924"}
{"text": "Explore possible differences in perceived barriers between two groups .Assess the relevance and influence of knowledge management ( KM ) on Responsibility / Trust ( R&T ) and Barriers / Threats ( B&T ) .", "label": "", "metadata": {}, "score": "83.15201"}
{"text": "As noted above , we also plan to perform sensitivity analyses for the exclusion ( separately ) of the BEST and CAPRICORN trials .If data from the eligible trials are unobtainable , then analysis using a combination of IPD and aggregate data will be considered [ 24 ] .", "label": "", "metadata": {}, "score": "83.227806"}
{"text": "Mean 1 year .( metoprolol XL ) .Age 40 to 80 .zero lost .COPERNICUS .Severe HF .15 % carvedilol , 19 % placebo / .", "label": "", "metadata": {}, "score": "83.26764"}
{"text": "PubMed View Article .MERIT - HF Study Group : Effect of metoprolol CR / XL in chronic heart failure : Metoprolol CR / XL Randomised Intervention Trial in Congestive Heart Failure ( MERIT - HF ) .", "label": "", "metadata": {}, "score": "83.281876"}
{"text": "The Beta - Blockers in Heart Failure Collaborative Group ( BB - HF ) was formed to obtain and analyze individual patient data from the major randomized controlled trials of beta - blockers in heart failure .", "label": "", "metadata": {}, "score": "83.55257"}
{"text": "20 % carvedilol , 18 % placebo / .Mean 1.3 years .( carvedilol ) .endpoint - driven .BEST .Symptomatic HF .", "label": "", "metadata": {}, "score": "83.615074"}
{"text": "Pioglitazone was associated with a higher incidence of hospitalization for HF without an increase in cardiovascular mortality or worsening cardiac function ( by echocardiography ) .", "label": "", "metadata": {}, "score": "83.72713"}
{"text": "Declarations .Acknowledgements .Daphne Babalis : Clinical Trials and Evaluation Unit , Royal Brompton Hospital / Imperial College London , UK .David Chen : GlaxoSmithKline , Cardiovascular and Metabolism Medicine Development Center , Philadelphia , PA , USA .", "label": "", "metadata": {}, "score": "83.88738"}
{"text": "doi:10.1016/j.amjcard.2007.03.084 . . .Resource utilization and costs in the Candesartan in Heart failure : Assessment of Reduction in Mortality and morbidity ( CHARM ) programme .", "label": "", "metadata": {}, "score": "83.92816"}
{"text": "A placebo - controlled trial of captopril in refractory chronic congestive heart failure .J Am Coll Cardiol .Captopril - Digoxin Multicenter Research Group .", "label": "", "metadata": {}, "score": "84.02384"}
{"text": "A placebo - controlled trial of captopril in refractory chronic congestive heart failure .J Am Coll Cardiol .Captopril - Digoxin Multicenter Research Group .", "label": "", "metadata": {}, "score": "84.02384"}
{"text": "Statistical analysis .Due to the complexity of the statistical analyses , the following section represents the planned principal analyses ; some modifications and secondary analyses are likely to emerge during the project .", "label": "", "metadata": {}, "score": "84.037735"}
{"text": "Further , the benefits of beta - blockade in women are inconsistent .In comparison , the results from BEST , MERIT - HF and COPERNICUS found no significant benefit in women [ 16 , 28 , 29 ] .", "label": "", "metadata": {}, "score": "84.07883"}
{"text": "This gives ICERs of \u20ac7,538 ( 95 % CI \u20ac5325-\u20ac11 784 ) per QALY gained and \u20ac 7011 ( 95 % CI \u20ac 5346-\u20ac10 003 ) per life - year gained .", "label": "", "metadata": {}, "score": "84.27664"}
{"text": "Place holder to copy figure label and caption .BDI indicates Beck Depression Inventory .Tables .Table Graphic Jump Location Table 1 .Abramson JBerger AKrumholz HMVaccarino V Depression and risk of heart failure among older persons with isolated systolic hypertension .", "label": "", "metadata": {}, "score": "84.53385"}
{"text": "Lancet 2000;355:1575 - 1581 .Packer M , Bristow MR , Cohn JN et al .The effect of carvedilol on morbid- ity and mortality in patients with chronic heart failure .", "label": "", "metadata": {}, "score": "84.66591"}
{"text": "Effects of angiotensin converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure .Arch Intern Med 2000;160:53 - 60 .", "label": "", "metadata": {}, "score": "84.766815"}
{"text": "Circulation 2003(Suppl .IV ) , IV-447 .Chin MH , Friedmann PD , Cassel CK et al .Differences in generalist and specialist physicians ' and use of angiotensin - converting enzyme inhibi- tors for congestive heart failure .", "label": "", "metadata": {}, "score": "84.781006"}
{"text": "The survey was under the supervision of an independent Steering Committee ( Appendix I ) .At inclusion , patients were followed as outpatients by office or hospital - based cardiologists .", "label": "", "metadata": {}, "score": "84.97542"}
{"text": "Correspondence .The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians .The AMA designates this journal - based CME activity for a maximum of 1 AMA PRA Category 1 Credit TM per course .", "label": "", "metadata": {}, "score": "85.012856"}
{"text": "MERIT - HF Study Group .Effect of metoprolol CR / XL in chronic heart failure .Metoprolol CR / XL Randomised Intervention Trial in Congestive Heart Failure ( MERIT - HF ) .", "label": "", "metadata": {}, "score": "85.094475"}
{"text": "Dr Kraus reported receiving grants or funding from the National Institutes of Health .Dr Blumenthal reported receiving grants or funding from the National Institutes of Health .", "label": "", "metadata": {}, "score": "85.20906"}
{"text": "The LVEF was determined using 2-dimensional echocardiography .Apical 4-chamber and 2-chamber images of the heart were acquired by a single sonographer using an ultrasound machine and were stored as digital loops .", "label": "", "metadata": {}, "score": "85.69867"}
{"text": "Thiazolidinediones are associated with fluid retention , often interpreted as worsening cardiac function , limiting their use in patients with heart failure ( HF ) .", "label": "", "metadata": {}, "score": "85.7814"}
{"text": "Letters .The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians .The AMA designates this journal - based CME activity for a maximum of 1 AMA PRA Category 1 Credit TM per course .", "label": "", "metadata": {}, "score": "85.810005"}
{"text": "Ms Houston Miller reported receiving personal income for consulting from Triage Wireless and receiving honoraria from Pfizer , CV Therapeutics , and AstraZeneca .Dr Pi\u00f1a reported receiving grants or funding from the National Institutes of Health , receiving personal income for consulting from the Food and Drug Administration , and receiving honoraria from AstraZeneca , Innovia , Merck , Novartis , Sanofi - Aventis , and Solvay .", "label": "", "metadata": {}, "score": "86.0152"}
{"text": "It is unknown if barriers to CDSSs are present and differ between HF nurses and cardiologists .Therefore the aims of this study are ; 1 .", "label": "", "metadata": {}, "score": "86.29819"}
{"text": "Pioglitazone and heart failure : results from a controlled study in patients with type 2 diabetes mellitus and systolic dysfunction .J Card Fail .[ Show abstract ] [ Hide abstract ] ABSTRACT :", "label": "", "metadata": {}, "score": "86.43549"}
{"text": "Sensitivity analyses varying the length of CRT - ICD battery life significantly affects the cost - effectiveness of CRT - ICD + MT compared with CRT - P + MT .", "label": "", "metadata": {}, "score": "86.552246"}
{"text": "Twenty - five car- diologists were selected in each country and were asked to recruit 20 consecutive patients .If they declined , they were replaced by the same random procedure .", "label": "", "metadata": {}, "score": "86.577385"}
{"text": "doi:10.1056/NEJM199108013250501 . . .Comparative effectiveness of beta - adrenergic antagonists ( atenolol , metoprolol tartrate , carvedilol ) on the risk of rehospitalization in adults with heart failure .", "label": "", "metadata": {}, "score": "86.70216"}
{"text": "doi:10.1161/CIRCULATIONAHA.108.793273 . . .Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy : MADIT - CRT ( Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy ) .", "label": "", "metadata": {}, "score": "87.01483"}
{"text": "Supplementary material Supplementary material is available at European Heart Journal online .Acknowledgements This study was made possible by an unrestricted grant from Bristol- Myers - Squibb .", "label": "", "metadata": {}, "score": "87.432846"}
{"text": "Explore the relationship between the effects of beta blockers and key baseline measurements including heart rate , blood pressure and weight .e ) .f ) .", "label": "", "metadata": {}, "score": "87.67526"}
{"text": "Procedure costs included ICU , CCU , CABG , PTCA , and heart transplantation .Procedure costs were based on the frequency and cost of events , and average costs for ICU and CCU .", "label": "", "metadata": {}, "score": "87.6918"}
{"text": "Samples were placed on ice and cold centrifuged at 1000 g for 10 minutes .The NT - proBNP measurements were performed within 4 hours of thawing using an electrochemiluminescence immunoassay ( Elecsys proBNP ; Roche Diagnostics Corp , Indianapolis , Ind ) in accord with the manufacturer 's instructions .", "label": "", "metadata": {}, "score": "88.00467"}
{"text": "In an analysis to examine the effect of exercise training by subgroup , we used the reported race categories \" black or African American \" and \" white \" and combined all others as \" other .", "label": "", "metadata": {}, "score": "88.19551"}
{"text": "5.7 % carvedilol , 7.8 % placebo / .Median 6.5 months .( carvedilol ) .zero lost .ANZ .Symptomatic HF due to CAD .", "label": "", "metadata": {}, "score": "88.315735"}
{"text": "Dr Keteyian reported receiving honoraria for lectures to scientific , educational , and community groups and receiving royalties from books published by Human Kinetics and McGraw - Hill .", "label": "", "metadata": {}, "score": "88.406555"}
{"text": "Cohn JN , Tognoni G.Valsartan Heart Failure Trial Investigators .A randomized trial of the angiotensin - receptor blocker valsartan in chronic heart failure .N Engl J Med .", "label": "", "metadata": {}, "score": "88.4184"}
{"text": "Cohn JN , Tognoni G.Valsartan Heart Failure Trial Investigators .A randomized trial of the angiotensin - receptor blocker valsartan in chronic heart failure .N Engl J Med .", "label": "", "metadata": {}, "score": "88.4184"}
{"text": "If all authors have none , check \" No potential conflicts or relevant financial interests \" in the box below .Please also indicate any funding received in support of this work .", "label": "", "metadata": {}, "score": "88.46149"}
{"text": "Doppler echocardiography was by far the most common second line test for the confir- mation of cardiac dysfunction with some variations across countries , whereas other imaging techniques were used mar- ginally .", "label": "", "metadata": {}, "score": "88.587524"}
{"text": "Access to the PDF is only available via article purchase .BACKGROUND : Studies in experimental models and preliminary clinical experience suggested a possible therapeutic role for the soluble tumor necrosis factor antagonist etanercept in heart failure .", "label": "", "metadata": {}, "score": "88.800354"}
{"text": "Methods The MAHLER Study is a multi - centre , observational study on the medical management and cost of CHF in six European countries ( France , Germany , Italy , The Netherlands , Spain , UK ) .", "label": "", "metadata": {}, "score": "88.81833"}
{"text": "\" [ Show abstract ] [ Hide abstract ] ABSTRACT : The B - type natriuretic peptides are now available on many automated clinical analysers .", "label": "", "metadata": {}, "score": "88.87025"}
{"text": "Financial Disclosures : Dr O'Connor reported receiving grants or funding , personal income for consulting , and honoraria from GE Medical , Roche , and the National Institutes of Health .", "label": "", "metadata": {}, "score": "88.881096"}
{"text": "To evaluate the effect of the angiotensin receptor blocker candesartan on New York Heart Association ( NYHA ) functional class in a broad spectrum of patients with chronic heart failure ( CHF ) .", "label": "", "metadata": {}, "score": "88.886955"}
{"text": "Statistical analyses were performed by the coordinating center ( Duke Clinical Research Institute , Durham , North Carolina ) using SAS software version 8.2 ( SAS Institute Inc , Cary , North Carolina ) .", "label": "", "metadata": {}, "score": "89.98773"}
{"text": "Davidson KWRieckman NLesperance F Psychological theories of depression : potential application for the prevention of acute coronary syndrome recurrence .Psychosom Med 2004;66165- 173 PubMed Link to Article .", "label": "", "metadata": {}, "score": "90.02701"}
{"text": "Davidson KWRieckman NLesperance F Psychological theories of depression : potential application for the prevention of acute coronary syndrome recurrence .Psychosom Med 2004;66165- 173 PubMed Link to Article .", "label": "", "metadata": {}, "score": "90.02701"}
{"text": "Study concept and design : O'Connor , Whellan , Lee , Keteyian , Cooper , Kraus , Kitzman , Blumenthal , Zannad , Pi\u00f1a .Acquisition of data : O'Connor , Whellan , Lee , Keteyian , Kraus , Kitzman , Rendall , McKelvie , Zannad , Pi\u00f1a .", "label": "", "metadata": {}, "score": "90.2661"}
{"text": "Obtained funding : O'Connor , Whellan , Lee , Keteyian , Kitzman .Administrative , technical , or material support : O'Connor , Whellan , Lee , Keteyian , Cooper , Kitzman , Blumenthal , Rendall , Fleg , Schulman , Zannad , Pi\u00f1a .", "label": "", "metadata": {}, "score": "90.58693"}
{"text": "Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal , circumferential , and radial strain in cardiac resynchronization therapy .J Am Coll Cardiol .", "label": "", "metadata": {}, "score": "90.728325"}
{"text": "Eval Health Prof 2002 , 25 : 76 - 97 .PubMed View Article .Copyright .\u00a9 Kotecha et al . ; licensee BioMed Central Ltd. 2013 .", "label": "", "metadata": {}, "score": "91.47478"}
{"text": "PubMed View Article .Australia / New Zealand Heart Failure Research Collaborative Group : Randomised , placebo - controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease .", "label": "", "metadata": {}, "score": "92.40579"}
{"text": "Pfeffer MA , Swedberg K , Granger CB , et al ; CHARM Investigators and Committees .Effects of candesartan on mortality and morbidity in patients with chronic heart failure : the CHARM - Overall Programme .", "label": "", "metadata": {}, "score": "92.73931"}
{"text": "Pfeffer MA , Swedberg K , Granger CB , et al ; CHARM Investigators and Committees .Effects of candesartan on mortality and morbidity in patients with chronic heart failure : the CHARM - Overall Programme .", "label": "", "metadata": {}, "score": "92.73931"}
{"text": "Biomarker and DNA Core Lab : Kirkwood Adams , MD ( University of North Carolina , Chapel Hill ) ; Mark Donahue , MD , Mike Felker , MD ( Duke University , Durham , North Carolina ) .", "label": "", "metadata": {}, "score": "93.10521"}
{"text": "Pool the adverse event and discontinuation data to assess the safety of beta - blockers in HF patients , particularly the rate of bradycardia and hypotension .", "label": "", "metadata": {}, "score": "93.337814"}
{"text": "Drafting of the manuscript : O'Connor , Whellan , Lee , Keteyian , Kraus , Kitzman .Critical revision of the manuscript for important intellectual content : O'Connor , Whellan , Lee , Keteyian , Cooper , Ellis , Leifer , Kraus , Kitzman , Blumenthal , Rendall , Houston Miller , Fleg , Schulman , McKelvie , Zannad , Pi\u00f1a .", "label": "", "metadata": {}, "score": "93.70971"}
{"text": "Continuous variables will be presented as mean and standard deviation ( or median and range if not normally distributed ) .Binary and categorical variables will be presented as frequencies and percentages .", "label": "", "metadata": {}, "score": "94.28267"}
{"text": "View Article .Dargie HJ : Effect of carvedilol on outcome after myocardial infarction in patients with left - ventricular dysfunction : the CAPRICORN randomised trial .", "label": "", "metadata": {}, "score": "94.455666"}
{"text": "Obtained funding : Sherwood , Blumenthal , and Waugh .Administrative , technical , and material support : Sherwood , Trivedi , Johnson , O'Connor , Adams , Waugh , Bensimhon , Gaulden , Christenson , and Hinderliter .", "label": "", "metadata": {}, "score": "95.17145"}
{"text": "Patients with heart failure are at increased risk of sudden death and death attributed to progressive pump failure .We assessed the effect of candesartan on cause - specific mortality in patients enrolled in the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity ( CHARM ) program .", "label": "", "metadata": {}, "score": "95.2038"}
{"text": "Adherence was measured as proportion of the scheduled weekday protocol - based telehealth sessions completed .Sample Size .Calculations were conducted using SAS version 9.1.3 ( SAS Institute Inc , Cary , NC ) using an alpha level of .05 for a 1-tailed test of significance .", "label": "", "metadata": {}, "score": "95.478004"}
{"text": "Echo Core Lab : Julius M. Gardin , MD ( director ) ; Renee L. Bess , BS , RDCS , RVT , Gerald I. Cohen , MD ( St John Hospital and Medical Center , Detroit , Michigan ) .", "label": "", "metadata": {}, "score": "95.8368"}
{"text": "Critical revision of the manuscript for important intellectual content : Sherwood , Blumenthal , O'Connor , Adams , Dupree , Waugh , Bensimhon , Koch , and Hinderliter .", "label": "", "metadata": {}, "score": "96.05123"}
{"text": "Published on behalf of the European Society of Cardiology .All rights reserved .\u00a9The Author 2012 .Circulation 2007 ; 116 : 1482 - 1487 .", "label": "", "metadata": {}, "score": "96.08484"}
{"text": "This reflects the fact that MAHLER was per- formed among cardiologists and not general practitioners with a high rate of prescription of first line tests such as elec- trocardiogram or X - ray .", "label": "", "metadata": {}, "score": "96.354034"}
{"text": "Results Patients In the MAHLER Study , 1410 evaluable patients were included : 248 in France , 251 in Germany and Italy , 246 in the Netherlands , 249 in Spain , and 165 in UK between November 2001 and April 2002 .", "label": "", "metadata": {}, "score": "96.37938"}
{"text": "Methodology and results were reviewed by the statistician co - author ( I.F. ) .SAS ( version 9.1 ) and R 2.14.0 were used for analyses .", "label": "", "metadata": {}, "score": "96.77251"}
{"text": "This review provides a switching protocol for transitioning stable patients from twice - daily carvedilol to once - daily carvedilol CR .Based on the findings from a head - to - head comparison study of carvedilol and metoprolol tartrate suggesting that carvedilol is associated with superior reductions in mortality and morbidity , physicians may consider switching patients with heart failure receiving beta - blockers who have not shown benefits in this setting .", "label": "", "metadata": {}, "score": "97.15193"}
{"text": "Vizentin ( Caverzere ) , Dr Massimo Zanella ( Copparo ) , Dr ssa Gabriella Zottarel ( San Biagio di Callalta ) .References 1 .", "label": "", "metadata": {}, "score": "97.272995"}
{"text": "The authors were not obliged to incorporate comments received from the sponsor .G.L.Y. and S.B. have no conflicts of interest .\u00a9The European Society of Cardiology 2006 .", "label": "", "metadata": {}, "score": "97.40427"}
{"text": "Unlike other Limitations We measured only ' positive ' adherence to care but could not evaluate the reasons why there was non - adherence .In particular , MAHLER did not record non - prescription of rec- ommended classes for poor tolerance or contraindication .", "label": "", "metadata": {}, "score": "97.879295"}
{"text": "This feature is provided as a courtesy .By using it you agree that that you are requesting the material solely for personal , non - commercial use , and that it is subject to the AMA 's Terms of Use .", "label": "", "metadata": {}, "score": "98.743805"}
{"text": "By using it you agree that that you are requesting the material solely for personal , non - commercial use , and that it is subject to the AMA 's Terms of Use .", "label": "", "metadata": {}, "score": "98.77951"}
{"text": "For Permissions , please e - mail : journals.permissions@oxfordjournals.org .Cardiac resynchronization for patients with heart failure due to left ventricular systolic dysfunction : a systematic review and meta - analysis accepted for publication .", "label": "", "metadata": {}, "score": "100.68097"}
{"text": "Clinical Trials and Evaluation Unit , Royal Brompton Hospital .Monash Centre of Cardiovascular , Research and Education in Therapeutics , Monash University .Department of Medicine , Universidad de Alcala , Hospital Universitario Ramon y Cajal .", "label": "", "metadata": {}, "score": "101.11043"}
{"text": "Differing provisions from the publisher 's actual policy or licence agreement may be applicable .", "label": "", "metadata": {}, "score": "102.11658"}
{"text": "Acquisition of data : Sherwood , Trivedi , Johnson , O'Connor , Adams , Dupree , Waugh , Bensimhon , Gaulden , and Hinderliter .Analysis and interpretation of data : Sherwood , Blumenthal , Trivedi , Johnson , O'Connor , Dupree , Bensimhon , Christenson , Koch , and Hinderliter .", "label": "", "metadata": {}, "score": "102.48091"}
{"text": "View Article .The carvedilol and ACE - inhibitor remodelling mild heart failure evaluation trial ( CARMEN ) .Cardiovasc Drugs Ther 2004 , 18 : 57 - 66 .", "label": "", "metadata": {}, "score": "102.79658"}
{"text": "Norwich Medical School , University of East Anglia .References .: Heart disease and stroke statistics-2010 update : a report from the American Heart Association .", "label": "", "metadata": {}, "score": "103.1645"}
{"text": "There was no heterogeneity in the response to candesartan between the CHARM component trials .CONCLUSIONS : Candesartan improves NYHA functional class to a similar extent to other proven treatments for CHF when added to these other treatments .", "label": "", "metadata": {}, "score": "104.50568"}
{"text": "Only content that has not been published , posted , or submitted elsewhere should be submitted .By submitting this Comment , you and any coauthors transfer copyright to the journal if your Comment is posted .", "label": "", "metadata": {}, "score": "105.75348"}
{"text": "A.1 .Appendix : Members of BB - HF Collaborative Group .A.1.1 .Steering Committee .A.1.2 .Statistical Team .Nicola Williams : Centre for Statistics in Medicine , University of Oxford , Oxford , UK.Douglas Altman : Centre for Statistics in Medicine , University of Oxford , Oxford , UK .", "label": "", "metadata": {}, "score": "107.50466"}
{"text": "If your institution uses Athens or Shibboleth authentication , please contact your site administrator to receive your user name and password .What is this ?", "label": "", "metadata": {}, "score": "108.41194"}
{"text": "If your institution uses Athens or Shibboleth authentication , please contact your site administrator to receive your user name and password .What is this ?", "label": "", "metadata": {}, "score": "108.41194"}
{"text": "doi:10.1001/jama.2009.454 .Athens and Shibboleth are access management services that provide single sign - on to protected resources .They replace the multiple user names and passwords necessary to access subscription - based content with a single user name and password that can be entered once per session .", "label": "", "metadata": {}, "score": "110.867966"}
{"text": "[ PubMed ID : 12585952 ] .Copyright \u00a9 American College of Physicians .The information contained herein should never be used as a substitute for good clinical judgment .", "label": "", "metadata": {}, "score": "111.11312"}
{"text": "Funding .The SHIFT study was funded by Servier , Suresnes , France .Funding to pay the Open Access publication charges for this article was provided by Servier , France .", "label": "", "metadata": {}, "score": "112.18872"}
{"text": "doi:10.1001/archinte.167.4.367 .Athens and Shibboleth are access management services that provide single sign - on to protected resources .They replace the multiple user names and passwords necessary to access subscription - based content with a single user name and password that can be entered once per session .", "label": "", "metadata": {}, "score": "113.60039"}
{"text": "Beta - Blocker Evaluation Survival Trial .CAPRICORN : .Carvedilol Post - Infarct Survival Control in LV Dysfunction Study .CHRISTMAS : .Carvedilol Hibernating Reversible Ischaemia Trial : Marker of Success Study .", "label": "", "metadata": {}, "score": "117.398315"}
{"text": "The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .Publisher conditions are provided by RoMEO .", "label": "", "metadata": {}, "score": "128.21399"}
